<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Genes (Basel)</journal-id>
<journal-id journal-id-type="iso-abbrev">Genes (Basel)</journal-id>
<journal-id journal-id-type="publisher-id">genes</journal-id>
<journal-title-group>
<journal-title>Genes</journal-title>
</journal-title-group>
<issn pub-type="epub">2073-4425</issn>
<publisher>
<publisher-name>MDPI</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27983607</article-id>
<article-id pub-id-type="pmc">5192499</article-id>
<article-id pub-id-type="doi">10.3390/genes7120123</article-id>
<article-id pub-id-type="publisher-id">genes-07-00123</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Study of the Genetic Etiology of Primary Ovarian Insufficiency: FMR1 Gene</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Barasoain</surname>
<given-names>Maitane</given-names>
</name>
<xref ref-type="aff" rid="af1-genes-07-00123">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Barrenetxea</surname>
<given-names>Gorka</given-names>
</name>
<xref ref-type="aff" rid="af2-genes-07-00123">2</xref>
<xref ref-type="aff" rid="af3-genes-07-00123">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Huerta</surname>
<given-names>Iratxe</given-names>
</name>
<xref ref-type="aff" rid="af1-genes-07-00123">1</xref>
<xref ref-type="aff" rid="af4-genes-07-00123">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Télez</surname>
<given-names>Mercedes</given-names>
</name>
<xref ref-type="aff" rid="af1-genes-07-00123">1</xref>
<xref ref-type="aff" rid="af4-genes-07-00123">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Criado</surname>
<given-names>Begoña</given-names>
</name>
<xref ref-type="aff" rid="af5-genes-07-00123">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Arrieta</surname>
<given-names>Isabel</given-names>
</name>
<xref ref-type="aff" rid="af1-genes-07-00123">1</xref>
<xref ref-type="corresp" rid="c1-genes-07-00123">*</xref>
</contrib>
</contrib-group>
<contrib-group>
<contrib contrib-type="editor">
<name>
<surname>Hirst</surname>
<given-names>Mark</given-names>
</name>
<role>Academic Editor</role>
</contrib>
</contrib-group>
<aff id="af1-genes-07-00123"><label>1</label>Department of Genetics, Physical Anthropology and Animal physiology, Faculty of Science and Technology, University of the Basque Country, Bilbao, 48940, Spain; <email>maitane.bhf@gmail.com</email> (M.B.); <email>iratxe.huerta@medikosta.com</email> (I.H.); <email>mertxe.telez@medikosta.com</email> (M.T.)</aff>
<aff id="af2-genes-07-00123"><label>2</label>Department of Medical-Surgical Specialities, Faculty of Medicine, University of the Basque Country, Bilbao, 48940, Spain; <email>gbarrenetxea@reproduccionbilbao.es</email></aff>
<aff id="af3-genes-07-00123"><label>3</label>Reproduction Bilbao, Bilbao, 48014, Spain</aff>
<aff id="af4-genes-07-00123"><label>4</label>Genetic Counseling and Prenatal Diagnosis Laboratory GENETIC, Bilbao, 48014, Spain</aff>
<aff id="af5-genes-07-00123"><label>5</label>Cooperativa de Ensino Superior Politecnico e Universitario (CESPU), Porto, 4760-409, Portugal; <email>mbegona.criado@ipsn.cespu.pt</email></aff>
<author-notes>
<corresp id="c1-genes-07-00123"><label>*</label>Correspondence: <email>mariaisabel.arrieta@ehu.eus</email>; Tel.: +34-946-012-605; Fax: +34-946-013-145</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>13</day>
<month>12</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="collection">
<month>12</month>
<year>2016</year>
</pub-date>
<volume>7</volume>
<issue>12</issue>
<elocation-id>123</elocation-id>
<history>
<date date-type="received">
<day>05</day>
<month>7</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>30</day>
<month>11</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>© 2016 by the authors; licensee MDPI, Basel, Switzerland.</copyright-statement>
<copyright-year>2016</copyright-year>
<license>
<license-p><!--CREATIVE COMMONS-->This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC-BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p>
</license>
</permissions>
<abstract>
<p>Menopause is a period of women’s life characterized by the cessation of menses in a definitive way. The mean age for menopause is approximately 51 years. Primary ovarian insufficiency (POI) refers to ovarian dysfunction defined as irregular menses and elevated gonadotrophin levels before or at the age of 40 years. The etiology of POI is unknown but several genes have been reported as being of significance. The <italic>fragile X mental retardation 1</italic> gene (<italic>FMR1</italic>) is one of the most important genes associated with POI. The <italic>FMR1</italic> gene contains a highly polymorphic CGG repeat in the 5′ untranslated region of exon 1. Four allelic forms have been defined with respect to CGG repeat length and instability during transmission. Normal (5–44 CGG) alleles are usually transmitted from parent to offspring in a stable manner. The full mutation form consists of over 200 repeats, which induces hypermethylation of the <italic>FMR1</italic> gene promoter and the subsequent silencing of the gene, associated with Fragile X Syndrome (FXS). Finally, <italic>FMR1</italic> intermediate (45–54 CGG) and premutation (55–200 CGG) alleles have been principally associated with two phenotypes, fragile X tremor ataxia syndrome (FXTAS) and fragile X primary ovarian insufficiency (FXPOI).</p>
</abstract>
<kwd-group>
<kwd>FMR1</kwd>
<kwd>POI</kwd>
<kwd>menopause</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="sec1-genes-07-00123">
<title>1. Menopause</title>
<p>The reproductive capacity of a woman depends principally on two factors, the number of follicles in the ovaries during the reproductive years and quality of oocytes within those follicles. The number of follicles is determined genetically before birth, during the embryonic development and it is termed ovarian follicular reserve. Only a few hundreds of these follicles complete their development, while most of them become atretic and are eliminated during the recruitment.</p>
<p>The initial recruitment and the resulting loss of follicles begin during the fetal stage and continue throughout the lifespan. When the ovarian reserve is below a certain threshold, some reproductive events occur, such as irregular menses, and finally this process ends in menopause. Menopause coincides with a recount of a few hundred follicles stored in the ovaries [<xref ref-type="bibr" rid="B1-genes-07-00123">1</xref>].</p>
<p>Menopause is a period of women’s life characterized by cessation of menses in a definitive manner. It occurs approximately at 50.7 years [<xref ref-type="bibr" rid="B2-genes-07-00123">2</xref>], however it ranges between 48 and 54 years. With respect to this this range, there is a differentiation between early menopause (40–44 years), late menopause (&gt;55 years) and premature menopause (&lt;40 years). The origin of menopause resides in the follicular depletion of the ovaries. The appearance of menopause can be natural, when it occurs gradually and progressively by the normal ageing of the ovary, or artificial, caused by the removal of the ovaries with or without hysterectomy or by radiotherapy or chemotherapy [<xref ref-type="bibr" rid="B3-genes-07-00123">3</xref>].</p>
<p>Ovaries age through quick depletion of follicles and consequently of oocytes. This process begins during the embryonic stage and extends to menopause. Usually, a healthy female possesses ~400,00 primordial follicles at the beginning of puberty and of these only 400–500 reach maturity during the reproductive life span of an adult female [<xref ref-type="bibr" rid="B4-genes-07-00123">4</xref>].</p>
<p>Depletion of the ovarian reserve implies a parallel growth of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) [<xref ref-type="bibr" rid="B5-genes-07-00123">5</xref>]. There is also a fall in anti-Müllerian hormone (AMH) because of a reduction of the antral follicle pool. This occurs parallel to the reduction of the primordial follicles pool.</p>
<p>The diagnosis of menopause is principally clinical, after one year of amenorrhea. The hormones analyzed for the diagnosis are primarily FSH, whose levels should be higher than 40 IU/L, and estradiol, with values below 30–50 pg/mL. Currently, AMH levels are considered an adequate marker of follicular depletion. This hormone varies minimally during the cycle and its fall to undetectable levels could be a signal of the start of the last stage of menopausal transition [<xref ref-type="bibr" rid="B3-genes-07-00123">3</xref>].</p>
</sec>
<sec id="sec2-genes-07-00123">
<title>2. Primary Ovarian Insufficiency</title>
<p>Primary ovarian insufficiency (POI) is defined as the loss of the ovarian hormonal function in a woman before or at the age of 40 years [<xref ref-type="bibr" rid="B6-genes-07-00123">6</xref>]. This term was suggested by Welt [<xref ref-type="bibr" rid="B7-genes-07-00123">7</xref>] and three subtypes are differentiated:
<list list-type="simple"><list-item><label>-</label><p>Occult: normal levels of gonadotrophins, reduced fecundity and regular menses.</p></list-item><list-item><label>-</label><p>Biochemical: elevated levels of gonadotrophins, reduced fecundity and regular menses.</p></list-item><list-item><label>-</label><p>Overt: elevated levels of gonadotrophins, reduced fecundity and irregular or absent menses.</p></list-item></list></p>
<p>There has been controversy with the term POI. Previously, the term premature ovarian failure (POF) was used and it was defined as cessation of menstrual cycles before the age of 40 years with deficiency of sexual hormones and elevated levels of gonadotrophins [<xref ref-type="bibr" rid="B8-genes-07-00123">8</xref>]. The use of POF suggests an irreversible failure of the ovary but in some cases ovarian failure is not permanent: Fifty percent of women with POI present intermittent ovarian function and 5%–10% conceive spontaneously [<xref ref-type="bibr" rid="B9-genes-07-00123">9</xref>,<xref ref-type="bibr" rid="B10-genes-07-00123">10</xref>]. In these cases, the use of the term POF is not entirely adequate and consequently the term POI was proposed.</p>
<p>The common symptom among women with POI is reduced fertility, but premature estrogen deficiency has other clinical consequences including higher risk of osteoporosis or mortality increase due to cardiovascular causes [<xref ref-type="bibr" rid="B11-genes-07-00123">11</xref>]. In addition, women suffering a premature menopause have higher risk of problems such as anxiety, depression and other psychological symptoms compared to women with normal ovarian function [<xref ref-type="bibr" rid="B12-genes-07-00123">12</xref>,<xref ref-type="bibr" rid="B13-genes-07-00123">13</xref>,<xref ref-type="bibr" rid="B14-genes-07-00123">14</xref>].</p>
<sec>
<title>Etiology of POI</title>
<p>The etiology of POI is unknown, but some mechanisms have been considered, including a reduction in the number of oocytes or ovarian reserve, an increase in follicle destruction and alterations in the follicular recruitment and maturation.</p>
<p>Although the majority of POI cases are idiopathic, there are three principal causes for the development of this pathology: chromosomal abnormalities, genetic causes and autoimmune alterations [<xref ref-type="bibr" rid="B15-genes-07-00123">15</xref>]. With lower implication, metabolic defects and other causes have been related to POI.</p>
<p>
<bold>a. Chromosomal abnormalities:</bold>
</p>
<p>The X chromosome includes important genes for determining ovarian function. Numerical or structural changes in the X chromosome, including Turner’s syndrome (45, X), triple X syndrome (47, XXX) and deletions or translocations in this chromosome, have been associated with POI, as reviewed by Fortuño and Labarta [<xref ref-type="bibr" rid="B16-genes-07-00123">16</xref>].</p>
<p>
<bold>b. Genetic causes:</bold>
</p>
<p>A high number of candidate genes associated with POI have been analyzed (<xref ref-type="table" rid="genes-07-00123-t001">Table 1</xref>). The majority of them are related to different processes of the follicular maturation and many of them have their locus in the X chromosome. These are some of the most important genes related with POI, although only the association of <italic>fragile X mental retardation 1</italic> (<italic>FMR1</italic>) and <italic>bone morphogenetic protein 15</italic> (<italic>BMP15</italic>) genes has been thoroughly demonstrated:
<list list-type="simple"><list-item><label>-</label><p><italic>FMR1</italic> gene. It has its locus in Xq27.3 and many studies propose that premutation of the <italic>FMR1</italic> gene is the cause of approximately 6% of POI cases [<xref ref-type="bibr" rid="B1-genes-07-00123">1</xref>,<xref ref-type="bibr" rid="B17-genes-07-00123">17</xref>,<xref ref-type="bibr" rid="B18-genes-07-00123">18</xref>,<xref ref-type="bibr" rid="B19-genes-07-00123">19</xref>].</p></list-item><list-item><label>-</label><p><italic>FMR2</italic> gene. It is also denominated AF4/FMR2 Family Member 2 (AFF2) and is localized in Xq28. Murray et al. in 1998 [<xref ref-type="bibr" rid="B20-genes-07-00123">20</xref>] found microdeletions in this gene as the cause of the 1.5% of the analyzed POI women.</p></list-item><list-item><label>-</label><p>BMP15, localized in Xp11.22, is part of the transforming growth factor β (TFG-β) family involved in cellular processes that occur during embryonic development and tissue formation. BMP15 protein is expressed specifically in the oocyte and its expression maintains high levels during follicular maturation and ovulation [<xref ref-type="bibr" rid="B21-genes-07-00123">21</xref>]. Mutations of this gene in mice and sheep have been identified that give rise to altered ovulation [<xref ref-type="bibr" rid="B21-genes-07-00123">21</xref>,<xref ref-type="bibr" rid="B22-genes-07-00123">22</xref>].</p></list-item><list-item><label>-</label><p><italic>Growth differentiation factor 9</italic> (GDF9), localized in 5q31.1, encodes a member of the transforming growth factor expressed in the oocyte and it plays its role in differentiation of the own oocyte and granulosa and thecal cells. Mutations in single nucleotide polymorphisms (SNPs) of this gene have been identified among patients with POI [<xref ref-type="bibr" rid="B23-genes-07-00123">23</xref>].</p></list-item><list-item><label>-</label><p><italic>Luteinizing hormone receptor</italic> (<italic>LHR</italic>) and <italic>follicle-stimulating hormone receptor</italic> (<italic>FSHR</italic>) are localized in chromosome 2, in <italic>loci</italic> 2p21 and 2p21-p16 respectively. They encode receptors for gonadotropic hormones FSH and LH. These hormones are essential for the right function of menstrual activity. Both regulate the production of sex steroid hormones, estradiol and progesterone, by thecal and granulosa cells rounding the growing follicle. Alterations in these receptors could reduce the ability of these receptors to join these hormones, decreasing its activity.</p></list-item><list-item><label>-</label><p>Recently, <italic>stromal antigen 3</italic> (<italic>STAG3</italic>) gene, in 7q22.1, has also been associated with POI. This gene encodes a subunit of the cohesin ring specific of meiosis and it is also connected with azoospermia [<xref ref-type="bibr" rid="B24-genes-07-00123">24</xref>,<xref ref-type="bibr" rid="B25-genes-07-00123">25</xref>].</p></list-item></list></p>
<p>
<bold>c. Autoimmune alterations:</bold>
</p>
<p>Autoimmune mechanisms are the cause in 14.3% of POI cases [<xref ref-type="bibr" rid="B26-genes-07-00123">26</xref>]. Associated autoimmune disorders are, among others, Addison’s disease, dry-eye syndrome or Sjógren’s syndrome, autoimmune polyglandular syndrome, rheumatoid arthritis, or systemic lupus erythematosus [<xref ref-type="bibr" rid="B27-genes-07-00123">27</xref>].</p>
<p>Some antibodies have been investigated as serological markers of ovarian immunity, such as 3β-hydroxysteroid dehydrogenase (3β-HSD) autoantibodies, antibodies against FSH and LH receptors, anti-thyroid antibodies, autoantibodies against luteal body, pellucid zone or oocytes [<xref ref-type="bibr" rid="B28-genes-07-00123">28</xref>]. Goswami et al. [<xref ref-type="bibr" rid="B29-genes-07-00123">29</xref>] assessed the prevalence of thyroid peroxidase autoantibodies in patients with POI and they showed that 24% of POI cases presented with these antibodies. However, none of these antibodies is considered valid as serological marker that can confirm a diagnostic of autoimmune POI.</p>
<p>
<bold>d. Metabolic and other causes:</bold>
</p>
<p>Some inherited enzymatic pathway disorders have been associated with ovarian follicular dysfunction leading to POI, as reviewed by Cox and Liu [<xref ref-type="bibr" rid="B30-genes-07-00123">30</xref>].</p>
<p>Pelvic surgery or cancer treatment could lead to POI. Radiotherapy and chemotherapy are strongly related to the development of this pathology. The effect of these treatments in the loss of ovarian function depend on dose, patient’s ovarian reserve and age [<xref ref-type="bibr" rid="B9-genes-07-00123">9</xref>].</p>
</sec>
</sec>
<sec id="sec3-genes-07-00123">
<title>3. <italic>FMR1</italic> Gene</title>
<p><italic>FMR1</italic> gene was identified in 1991 [<xref ref-type="bibr" rid="B31-genes-07-00123">31</xref>,<xref ref-type="bibr" rid="B32-genes-07-00123">32</xref>,<xref ref-type="bibr" rid="B33-genes-07-00123">33</xref>] and coincides with the fragile site FRAXA localized in Xq27.3.</p>
<sec id="sec3dot1-genes-07-00123">
<title>3.1. Characteristics of the Gene</title>
<p>The <italic>FMR1</italic> gene is 40 kb in length and contains 17 exons. The ~4 kb full length mRNA [<xref ref-type="bibr" rid="B34-genes-07-00123">34</xref>] codes for a protein with a maximum length of 632 amino acids and a molecular mass of 69 kDa called <italic>fragile mental retardation protein</italic> (FMRP).</p>
<p>The gene contains a highly polymorphic CGG repeat in the 5′ untranslated region (UTR) of the exon 1. It shows also a CpG island located 250 bp upstream the repeat [<xref ref-type="bibr" rid="B35-genes-07-00123">35</xref>].</p>
</sec>
<sec id="sec3dot2-genes-07-00123">
<title>3.2. Alleles</title>
<p>The CGG repeat sequence is polymorphic in length and four alleles are differentiated:
<list list-type="simple"><list-item><label>-</label><p>Normal: It ranges from 5-4 CGG repeats with a mode in 30 repeats</p></list-item><list-item><label>-</label><p>Intermediate or grey zone: this class includes alleles with sizes at the high end of normal range, from 45 to 54 repeats. These alleles are found in 5%–9% of the general population [<xref ref-type="bibr" rid="B36-genes-07-00123">36</xref>,<xref ref-type="bibr" rid="B37-genes-07-00123">37</xref>,<xref ref-type="bibr" rid="B38-genes-07-00123">38</xref>].</p></list-item><list-item><label>-</label><p>Premutation: Alleles with repeat sizes from 55 to 200 repeats. The prevalence of premutation alleles in the general population is estimated to be 1:130–250 among women and 1:250–810 among men [<xref ref-type="bibr" rid="B39-genes-07-00123">39</xref>,<xref ref-type="bibr" rid="B40-genes-07-00123">40</xref>,<xref ref-type="bibr" rid="B41-genes-07-00123">41</xref>].</p></list-item><list-item><label>-</label><p>Mutation: It includes alleles with more than 200 CGG repeats. A prevalence is estimated of 1:4000 men and approximately 1:5000–8000 women [<xref ref-type="bibr" rid="B42-genes-07-00123">42</xref>,<xref ref-type="bibr" rid="B43-genes-07-00123">43</xref>].</p></list-item></list></p>
<p>There is no consensus about the estimated prevalence of <italic>FMR1</italic> alleles and this prevalence varies between geographical areas and the population assessed [<xref ref-type="bibr" rid="B41-genes-07-00123">41</xref>,<xref ref-type="bibr" rid="B44-genes-07-00123">44</xref>,<xref ref-type="bibr" rid="B45-genes-07-00123">45</xref>].</p>
</sec>
<sec id="sec3dot3-genes-07-00123">
<title>3.3. Transcriptional Regulation</title>
<p>Among carriers of normal, intermediate and premutation alleles, <italic>FMR1</italic> gene is transcriptionally active and FMRP is produced. However, when the number of repeats is over 200, cytosines of the CGG sequence and the ones of the upstream CpG island are methylated, leading to the silencing of the gene and the resulting absence of FMRP [<xref ref-type="bibr" rid="B46-genes-07-00123">46</xref>]. The absence of this protein is the principal cause of fragile X syndrome (FXS).</p>
<p>The epigenetic phenomenon of methylation occurs in the 5′ position of cytosines and induces, on one hand, the condensation of the chromatin and, on the other hand, it prevents the binding of transcription factors such as upstream stimulatory factor (USF)1, USF2 and nuclear respiratory factor (NRF)-1.</p>
<p>Changes in histones H3 and H4 have been also described. These histones are associated with the 5′UTR region of the <italic>FMR1</italic> gene and normally they are acetylated in their lysine residues. In mutated cells this acetylation is reduced which suggests that methyl CpG binding proteins recruit histone deacetylases which in turn induce chromatin condensation and prevent the transcription machinery from binding [<xref ref-type="bibr" rid="B47-genes-07-00123">47</xref>]. It has been observed that H3 shows lysine 4 demethylated and lysine 9 methylated [<xref ref-type="bibr" rid="B48-genes-07-00123">48</xref>].</p>
<p>In vitro treatment of mutated hypermethylated cells with methylation inhibitors, such as 5-azadeoxycytidine (5-aza-dC), partially reactivates genetic expression, demonstrating that methylation is the cause of genetic inactivation [<xref ref-type="bibr" rid="B49-genes-07-00123">49</xref>]. Normally, active <italic>FMR1</italic> gene has an open chromatin structure but when CGG repeat expansion occurs it leads to deacetylation and methylation of the CGG repeat and its promotor resulting in a packed chromatin, and causing the inactivation of the gene. Treatment of fragile X cell lines with 5-aza-dC produces demethylation and acetylation so that chromatin is open and transcription is partially recovered [<xref ref-type="bibr" rid="B50-genes-07-00123">50</xref>].</p>
</sec>
<sec id="sec3dot4-genes-07-00123">
<title>3.4. Instability of CGG Repeat</title>
<p>Characterization of <italic>FMR1</italic> gene brings to light a new type of mutation mechanism based in expansion of microsatellite sequences. According to Pearson et al. [<xref ref-type="bibr" rid="B51-genes-07-00123">51</xref>], the repeat mutation process is dynamic, with products that continue to mutate within tissues and across generations. The initial change in a microsatellite locus increases the probability of subsequent changes towards mutation. Therefore, longer sequences are more likely to undergo an expansion mutation than shorter ones. Moreover, length of the repeat sequence correlates with disease severity and age of onset: the more repeats, the more severe the disease and the earlier its onset. This is what is known as genetic anticipation [<xref ref-type="bibr" rid="B51-genes-07-00123">51</xref>,<xref ref-type="bibr" rid="B52-genes-07-00123">52</xref>].</p>
<p>Several pathologies such as Huntington´s disease, myotonic dystrophy or Kennedy’s disease are caused by trinucleotide expansions. These expansions can result in two mechanisms, loss or gain of function. Fragile X syndrome is an example of loss-of-function mechanism in which the gene product is either not produced or produced at lower levels. When there is a gain of function, mRNA or protein attain a new cellular function depending on the localization of the expansion in the gene [<xref ref-type="bibr" rid="B52-genes-07-00123">52</xref>].</p>
<p>There are some risk factors influencing the instability of <italic>FMR1</italic> CGG repeat during transmission:
<list list-type="simple"><list-item><label>-</label><p>Number of repeats: The risk of expansion increases with the length of the repeat. Normal alleles are usually transmitted from parent to offspring in a stable manner. Intermediate alleles can be unstable upon transmission, leading to a full mutation in several generations. However, some authors reported an expansion of an intermediate allele to a full mutation in only two generations [<xref ref-type="bibr" rid="B53-genes-07-00123">53</xref>,<xref ref-type="bibr" rid="B54-genes-07-00123">54</xref>,<xref ref-type="bibr" rid="B55-genes-07-00123">55</xref>]. Premutation alleles are associated to a high risk of expansion to full mutation in one generation [<xref ref-type="bibr" rid="B56-genes-07-00123">56</xref>].</p></list-item><list-item><label>-</label><p>Sex of the transmitting parent: Among normal and intermediate alleles, transmission from a male is less stable than from a female. However, when a premutation allele is transmitted by a female, CGG repeat suffers an expansion in almost all cases, although not always to full mutation. Moreover, among females, instability is at the same time proportional to the length of the repeat, so that alleles with more CGGs have a higher risk of expansion [<xref ref-type="bibr" rid="B56-genes-07-00123">56</xref>,<xref ref-type="bibr" rid="B57-genes-07-00123">57</xref>]. When premutation is transmitted by a male, the CGG repeat can expand, contract or remain unchanged, with the risk of expansion to full mutation being infrequent.</p></list-item><list-item><label>-</label><p>Purity of the repeat: CGG repeat is not pure; it is interrupted by an AGG trinucleotide. In the general population, CGG repeats are interrupted every 9–10 repeats [(CGG)<sub>9</sub>AGG(CGG)<sub>9</sub>AGG(CGG)<sub>n</sub>] [<xref ref-type="bibr" rid="B58-genes-07-00123">58</xref>]. Normal and intermediate alleles have usually two interruptions [<xref ref-type="bibr" rid="B59-genes-07-00123">59</xref>], whereas premutation alleles tend to have one or no AGGs at the 5′ end of the repeat [<xref ref-type="bibr" rid="B60-genes-07-00123">60</xref>,<xref ref-type="bibr" rid="B61-genes-07-00123">61</xref>,<xref ref-type="bibr" rid="B62-genes-07-00123">62</xref>]. The length of pure CGG repeats is also important. In 1994, Kunst and Warren [<xref ref-type="bibr" rid="B63-genes-07-00123">63</xref>] established that alleles with more than 24 pure CGG repeats will be unstably transmitted. More recently, it has been shown that there is a strong association between number of AGG interruptions and stability of the repeat [<xref ref-type="bibr" rid="B64-genes-07-00123">64</xref>,<xref ref-type="bibr" rid="B65-genes-07-00123">65</xref>].</p></list-item><list-item><label>-</label><p>“<italic>cis</italic>” elements: “<italic>cis</italic>” elements with the <italic>FMR1</italic> gene can affect the stability of the repeat. The more studied are flanking microsatellites and (SNPs). Mutated alleles are in linkage disequilibrium with flanking microsatellite markers, like DXS548 and FRAXAC1 [<xref ref-type="bibr" rid="B66-genes-07-00123">66</xref>]. It has also been suggested that SNPs can proportionate an advance in the study of CGG repeat instability. A research from Brightwell et al. in 2002 [<xref ref-type="bibr" rid="B67-genes-07-00123">67</xref>] noted that association between SNP ATL1 (rs4949:A&gt;G) and flanking microsatellite markers reflect the mutational history of CGG repeat expansion. Previous investigations of our group do not support this suggestion [<xref ref-type="bibr" rid="B68-genes-07-00123">68</xref>].</p></list-item></list></p>
</sec>
<sec id="sec3dot5-genes-07-00123">
<title>3.5. FMRP</title>
<p>FMRP is expressed preferentially in brain and testis. It has an important role in the regulation of protein synthesis in dendrites of the neurons [<xref ref-type="bibr" rid="B69-genes-07-00123">69</xref>], necessary for learning and memory [<xref ref-type="bibr" rid="B70-genes-07-00123">70</xref>].</p>
<p>FMRP is an RNA binding protein whose subcellular distribution is principally cytoplasmic. However, some isoforms are localized in the nucleus, which is consistent with the nuclear localization (NLS) and exportation (NES) signals of the protein. This indicates that FMRP shuttles between nucleus and cytoplasm [<xref ref-type="bibr" rid="B71-genes-07-00123">71</xref>].</p>
<p>The best characterized motifs are the ones responsible of its mRNA binding: two <italic>K homology</italic> (KH) domains in exons 8 and 10, an RGG box (arginine-glycine-arginine) in exon 15 [<xref ref-type="bibr" rid="B72-genes-07-00123">72</xref>] and an RNA binding domain in the amino terminal region of the protein [<xref ref-type="bibr" rid="B73-genes-07-00123">73</xref>]. The RGG box binds to a G-quartet structure present in several mRNAs associated with FMRP. At the same time, KH domains are important for the interaction between FMRP and polyribosomes.</p>
<p>FMRP associates with polyribosomes of the endoplasmic reticulum and with free ribosomes in the cytoplasm in an RNA-dependent manner via ribonucleoprotein particles (RNP). These RNPs contain proteins such as FXR1P and FXR2P, homologs to FMRP, nucleolin, Y-box Binding Protein 1 (YB-1), Nuclear FMRP Interacting Protein 1 (NUFIP1), Cytoplasmic FMRP Interacting Protein 1 (CYFIP1) and Cytoplasmic FMRP Interacting Protein 2 (CYFIP2) [<xref ref-type="bibr" rid="B50-genes-07-00123">50</xref>]. As a consequence of this association, FMRP abolishes the translation of a specific group of mRNAs [<xref ref-type="bibr" rid="B74-genes-07-00123">74</xref>]. Several works have identified some of these RNAs and have shown that these RNAs encode for proteins with an important role in neuronal function, synaptic plasticity and neuronal maturation [<xref ref-type="bibr" rid="B75-genes-07-00123">75</xref>,<xref ref-type="bibr" rid="B76-genes-07-00123">76</xref>].</p>
<p>Synaptic plasticity is essential for memory and learning and includes the long-term potentiation (LTP) and long-term depression (LTD). Synaptic plasticity is expressed at a pre- and post-synaptic level. At a post-synaptic level, LTD can be produced by the activation of <italic>N</italic>-methyl-<sc>d</sc>-aspartic acid receptors (NMDA) or metabotropic glutamate receptors (mGluR). At the same time, this activation induces the internalization of AMPA receptors, necessary for LTD, and the expression of FMRP [<xref ref-type="bibr" rid="B77-genes-07-00123">77</xref>] and other proteins.</p>
<p>According to the denominated “metabotropic glutamate receptors (mGluR) theory of fragile X syndrome” proposed by Bear et al. in 2004 [<xref ref-type="bibr" rid="B78-genes-07-00123">78</xref>]: as a consequence of the synthesis of FMRP, this protein acts as an inhibitor of the translation of certain proteins that reduce the internalization of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors. When FMRP is absent, like in FXS individuals, this internalization increases resulting in an excess of LTD [<xref ref-type="bibr" rid="B69-genes-07-00123">69</xref>].</p>
<p>Some works in FMR1 knock-out mice have shown that the use of glutamate 5 receptor (mGluR5) antagonists, such as 2-methyl-6-(phenylethynyl)pyridine (MPEP), reduces the internalization of AMPA receptors caused by FMRP absence [<xref ref-type="bibr" rid="B79-genes-07-00123">79</xref>].</p>
</sec>
<sec id="sec3dot6-genes-07-00123">
<title>3.6. Associated Pathologies</title>
<p><italic>FMR1</italic> gene is associated principally with three pathologies: FXS, tremor ataxia syndrome (FXTAS) and primary ovarian insufficiency (FXPOI).</p>
<p>FXS etiology is basically CGG trinucleotide repeat expansion in the 5′UTR region of <italic>FMR1</italic> gene. It has been proposed that the <italic>FMR1</italic> gene is uniquely responsible for FXS [<xref ref-type="bibr" rid="B71-genes-07-00123">71</xref>]. Premutated alleles, of between 55 and 200 CGG repeats, were not associated with any pathology until recently but nowadays they are clearly related to FXPOI and FXTAS. Intermediate or grey zone alleles, between 35 and 54 CGG repeats, are also related to the development of these two pathologies.</p>
<p>Presence of phenotypic characteristics associated with premutation alleles led to analysis of <italic>FMR1</italic> expression. Research of Tassone et al. [<xref ref-type="bibr" rid="B80-genes-07-00123">80</xref>,<xref ref-type="bibr" rid="B81-genes-07-00123">81</xref>] and Tassone and Hagerman [<xref ref-type="bibr" rid="B82-genes-07-00123">82</xref>] showed that <italic>FMR1</italic>-mRNA levels are increased approximately fivefold within premutation carriers (from two to ten times the normal), although protein expression is slightly reduced. In 2011, Tassone et al. [<xref ref-type="bibr" rid="B83-genes-07-00123">83</xref>] determined that in these premutation alleles there are different transcriptional start sites and polyadenylation sites leading to the different expression levels of these alleles with respect to normal ones. This, together with the fact that permutation-associated pathologies do not appear among individuals with FXS, denotes that the mechanism of these pathologies is different from that of FXS.</p>
<p>
<bold>a. Fragile X Syndrome</bold>
</p>
<p>Identification of Fragile X Syndrome:</p>
<p>In 1943 James Martin and Julia Bell [<xref ref-type="bibr" rid="B84-genes-07-00123">84</xref>] published the first pedigree showing a mental retardation associated to X chromosome. It was termed Martin-Bell syndrome. In 1974 Lehrke [<xref ref-type="bibr" rid="B85-genes-07-00123">85</xref>] estimated that 25%–50% of mental retardation could be attributed to mutations in the X chromosome. This estimation, while too high, established a new concept; X chromosome-linked mental retardation (XLMR).</p>
<p>In 1969 Lubs [<xref ref-type="bibr" rid="B86-genes-07-00123">86</xref>] detected a secondary constriction at the end of the long arm of a chromosome from group C in four mentally retarded males and three obligate carrier females of the same family. The chromosome was identified later by autoradiography as the X chromosome. The constriction, which served as a cytogenetic marker, was localized later in Xq27.3 [<xref ref-type="bibr" rid="B87-genes-07-00123">87</xref>], corresponding with the fragile site FRAXA. Richards et al. [<xref ref-type="bibr" rid="B88-genes-07-00123">88</xref>] reanalyzed the Martin-Bell pedigree and found that in affected males a cytogenetic variation was expressed as described previously by Lubs, which they defined as a fragile site. In that moment the syndrome was denominated fragile X syndrome (OMIM #300264).</p>
<p>Existence of a cytogenetic marker allowed the identification of a large number of families with the X chromosome marker, revealing the syndromic nature of this disorder. But analysis of these families pointed to an inheritance pattern more complex than a X-linked recessive inheritance pattern. There were affected heterozygous females and unaffected males that transmitted the cytogenetic marker to their daughters. In 1984 this phenomenon was denominated Sherman’s paradox [<xref ref-type="bibr" rid="B89-genes-07-00123">89</xref>] and its origin was not resolved until 1991, when the <italic>FMR1</italic> gene responsible of the syndrome was identified.</p>
<p>Fragile X Mutation:</p>
<p>The principal cause leading to variability in CGG repeat number is thought to be slipped-strand mispairing during DNA replication: when a new strand is synthesizing, the template strand, due to its repetitive nature, folds and form a secondary structure, so that DNA polymerase dissociates temporally from the template strand and re-associates to one or several previous repeat units, creating an extra loop of repetitive DNA that, if not repaired, would generate an expansion [<xref ref-type="bibr" rid="B47-genes-07-00123">47</xref>]. In 1994, Richards and Sutherland [<xref ref-type="bibr" rid="B90-genes-07-00123">90</xref>] proposed that this process would occur specifically in the Okazaki fragments.</p>
<p>Over the last years, cases of individuals carrying the full mutation but with a non-methylated CGG repeat and promoter have been described [<xref ref-type="bibr" rid="B91-genes-07-00123">91</xref>]. These individuals are phenotypically normal, proving that is the methylation and not the repeat expansion which causes the fragile X phenotype. There are also individuals whose mutation is methylated only in a percentage of its cells (methylation mosaicism) and that show a protein expression corresponding to non-methylated cells [<xref ref-type="bibr" rid="B92-genes-07-00123">92</xref>].</p>
<p>Moreover, more than 15 deletions, ranging from 1.6 kb to 13 mb, affecting part or the entire <italic>FMR1</italic> gene have been described, leading to FMRP absence and, therefore, generating the fragile X phenotype [<xref ref-type="bibr" rid="B93-genes-07-00123">93</xref>]. There are also point mutations leading to this phenotype that do not cause FMRP absence [<xref ref-type="bibr" rid="B94-genes-07-00123">94</xref>,<xref ref-type="bibr" rid="B95-genes-07-00123">95</xref>,<xref ref-type="bibr" rid="B96-genes-07-00123">96</xref>]. For example, I304N mutation (replacement of an isoleucine by an asparagine in aminoacid 304) in the second KH domain leads to a FMRP protein that does not associate with polyribosomes [<xref ref-type="bibr" rid="B94-genes-07-00123">94</xref>].</p>
<p>Fragile X Phenotype:</p>
<p>FXS is the most common known cause of inherited intellectual disability and autism. Epidemiological studies estimate that prevalence of this syndrome in the general population is 1:2500–1:8000 females and approximately 1:5000 males [<xref ref-type="bibr" rid="B40-genes-07-00123">40</xref>,<xref ref-type="bibr" rid="B41-genes-07-00123">41</xref>,<xref ref-type="bibr" rid="B97-genes-07-00123">97</xref>].</p>
<p>It includes a wide range of clinical, cognitive and behavioral dysfunctions. Clinical features include a long and narrow face with a prominent jaw and forehead, large ears, unusually flexible fingers, flat feet, and enlarged testicles (macroorchidism) after puberty in males. At a cognitive level, 80%–90% of males with FXS present mild to moderate intellectual deficiency, with an important attention deficit and delayed development of speech and language. At a behavioral level, hyperactivity is characteristic, and one-third of individuals with FXS have autism [<xref ref-type="bibr" rid="B98-genes-07-00123">98</xref>,<xref ref-type="bibr" rid="B99-genes-07-00123">99</xref>]. Of these, 18%–36% meet the criteria for autism disorder (AD) and 43%–67% present an autistic spectrum disorder (ASD).</p>
<p>
<bold>b. Fragile X-Associated Tremor/Ataxia Syndrome</bold>
</p>
<p>FXTAS (OMIM #300263) was firstly described in 2001 by Hagerman, Leehey et al. [<xref ref-type="bibr" rid="B100-genes-07-00123">100</xref>] in older (50-60 years) male carriers of a premutation allele. These authors defined it as a multisystem neurological disorder with tremor and ataxia as principal features.</p>
<p>The presence of intranuclear inclusions along with clinical characteristics constitutes the key factor for FXTAS. These inclusions are widely distributed along the brain, principally in the hippocampus and amygdala [<xref ref-type="bibr" rid="B101-genes-07-00123">101</xref>,<xref ref-type="bibr" rid="B102-genes-07-00123">102</xref>]. Inclusions have been described in carrier males with alleles as small as 70 CGG repeats. They are ubiquitin positive and they have been localized in neurons and astrocytes. Number and size of inclusions increase with age, which is related with the progressive nature of the syndrome [<xref ref-type="bibr" rid="B103-genes-07-00123">103</xref>]. Number of inclusions is also related with CGG repeat size [<xref ref-type="bibr" rid="B102-genes-07-00123">102</xref>,<xref ref-type="bibr" rid="B104-genes-07-00123">104</xref>].</p>
<p>At a molecular level, an RNA toxic-gain-of-function mechanism has been proposed [<xref ref-type="bibr" rid="B105-genes-07-00123">105</xref>]. <italic>FMR1</italic> transcripts with expanded CGG repeat are incorporated in a messenger ribonucleoprotein (mRNP) particle and translocated out of the nucleus. These transcripts do not join to the 40S ribosomal subunit and consequently translation is affected, reducing the levels of FMRP in the nerve cell. In response to lowered FMRP levels, an increase in transcription factors is produced, leading to a growth of <italic>FMR1</italic> transcription and therefore to an increase in <italic>FMR1</italic>-mRNA levels [<xref ref-type="bibr" rid="B59-genes-07-00123">59</xref>].</p>
<p>Alternatively, <italic>FMR1</italic> transcripts with long CGG repeats may sequester high quantities of CGG-binding proteins resulting also in increased <italic>FMR1</italic> transcription. Nerve cells attempt to eliminate the raised <italic>FMR1</italic> transcripts by the use of chaperones and components of the ubiquitin–proteasome degradation pathway. When this is not achieved, intranuclear inclusions are formed. These inclusions trigger neurodegeneration by activation of neurotoxic signaling pathways.</p>
<p>Although this syndrome was associated exclusively with carriers of premutation alleles, some cases of FXTAS among carriers of intermediate alleles have recently been published [<xref ref-type="bibr" rid="B106-genes-07-00123">106</xref>,<xref ref-type="bibr" rid="B107-genes-07-00123">107</xref>]. It has also been observed in individuals with full mutation and lack of methylation or mosaicism. FXTAS can also be present among females carrying premutation alleles, though with a less severe phenotype [<xref ref-type="bibr" rid="B108-genes-07-00123">108</xref>].</p>
</sec>
</sec>
<sec id="sec4-genes-07-00123">
<title>4. Fragile X-Associated Primary Ovarian Insufficiency (FXPOI)</title>
<p>Cronister et al. in 1991 [<xref ref-type="bibr" rid="B109-genes-07-00123">109</xref>] studied the correlation between <italic>FMR1</italic> gene and POI. They found that 13% of carrier women developed menopause before the age of 40. This percentage was significantly higher than in controls (5%). The identification of the <italic>FMR1</italic> gene in 1991 and the development of diagnostic techniques allowed the analysis and differentiation of <italic>FMR1</italic> alleles. Since 1994, evidence has shown that women carrying <italic>FMR1</italic> premutation and intermediate alleles have a risk of developing POI. Women with full mutation alleles, instead, have the same risk for POI as the general population (1%).</p>
<sec id="sec4dot1-genes-07-00123">
<title>4.1. POI and Premutation Alleles</title>
<p>Schwartz et al. [<xref ref-type="bibr" rid="B110-genes-07-00123">110</xref>] were the first to indicate that premutation carriers have a higher risk for POI than full mutation carriers. In 1999 Allingham-Hawkins et al. [<xref ref-type="bibr" rid="B111-genes-07-00123">111</xref>] determined in an international study the prevalence of POI among women carriers or non-carriers of premutation and full mutation alleles. They estimated that 16% of women carrying premutation alleles had POI. Other authors have confirmed this prevalence [<xref ref-type="bibr" rid="B112-genes-07-00123">112</xref>,<xref ref-type="bibr" rid="B113-genes-07-00123">113</xref>,<xref ref-type="bibr" rid="B114-genes-07-00123">114</xref>,<xref ref-type="bibr" rid="B115-genes-07-00123">115</xref>,<xref ref-type="bibr" rid="B116-genes-07-00123">116</xref>,<xref ref-type="bibr" rid="B117-genes-07-00123">117</xref>,<xref ref-type="bibr" rid="B118-genes-07-00123">118</xref>].</p>
<p>Therefore, only a percentage of women with premutation alleles suffer ovarian dysfunction. The identification of factors influencing clinical variability and that help to identify those women at risk of reproductive complications is important.</p>
<p>Concerning the molecular level, a non-linear association between premutation repeat size and risk for ovarian failure has been found [<xref ref-type="bibr" rid="B116-genes-07-00123">116</xref>,<xref ref-type="bibr" rid="B119-genes-07-00123">119</xref>,<xref ref-type="bibr" rid="B120-genes-07-00123">120</xref>], as those with premutation sizes of ~80–100 repeats have a higher risk for POI and earlier age of menopause. Additionally, some authors have shown that premutation carriers without signs of ovarian dysfunction have a reduction in the average age at menopause compared with non-carriers [<xref ref-type="bibr" rid="B113-genes-07-00123">113</xref>,<xref ref-type="bibr" rid="B121-genes-07-00123">121</xref>,<xref ref-type="bibr" rid="B122-genes-07-00123">122</xref>]. Sullivan et al. [<xref ref-type="bibr" rid="B116-genes-07-00123">116</xref>] established this reduction as five years. In addition, higher levels of FSH, an indicator of reduced ovarian function, were found in premutation carriers still cycling [<xref ref-type="bibr" rid="B123-genes-07-00123">123</xref>,<xref ref-type="bibr" rid="B124-genes-07-00123">124</xref>,<xref ref-type="bibr" rid="B125-genes-07-00123">125</xref>].</p>
</sec>
<sec id="sec4dot2-genes-07-00123">
<title>4.2. Premutation Alleles among Women with POI</title>
<p>Once the prevalence of POI among premutation carrier women was established, some studies were carried out to learn the frequency of premutation alleles among women with POI of unknown etiology. Conway et al. [<xref ref-type="bibr" rid="B17-genes-07-00123">17</xref>] were the first to perform an analysis in women with idiopathic POI. They found that the frequency of premutation alleles among women with sporadic POI and familial POI was 1.6% and 16% respectively.</p>
<p>After the study of Conway et al. other authors examined groups of women with POI and the estimation of premutation carriers has been established at 3.2% and 11.5% among women with sporadic or familial POI respectively [<xref ref-type="bibr" rid="B1-genes-07-00123">1</xref>,<xref ref-type="bibr" rid="B126-genes-07-00123">126</xref>].</p>
<p>Consequently, among women carrying FMR1 premutation alleles there is a continuum of diminished ovarian reserve that give rise to menstrual cycle irregularities, decreased fertility and hormone fluctuations. To involve all these traits, Welt [<xref ref-type="bibr" rid="B7-genes-07-00123">7</xref>] recommended the use of the term fragile X primary ovarian insufficiency (FXPOI) for the cases in which ovarian dysfunction was associated to FMR1 gene.</p>
</sec>
<sec id="sec4dot3-genes-07-00123">
<title>4.3. POI and Intermediate Alleles</title>
<p>POI has also been related to <italic>FMR1</italic> intermediate alleles [<xref ref-type="bibr" rid="B127-genes-07-00123">127</xref>,<xref ref-type="bibr" rid="B128-genes-07-00123">128</xref>]. Bretherick et al. [<xref ref-type="bibr" rid="B127-genes-07-00123">127</xref>] found that 14.2% of alleles among women with POI had between and including 35 and 54 repeats. Bodega et al. [<xref ref-type="bibr" rid="B128-genes-07-00123">128</xref>] proposed that this relation could depend on the AGG interspersion pattern.</p>
<p>Pastore et al. [<xref ref-type="bibr" rid="B129-genes-07-00123">129</xref>] indicated that alleles between 35 and 44 CGGs were overrepresented among women with diminished ovarian function but regular menses. Streuli et al. [<xref ref-type="bibr" rid="B118-genes-07-00123">118</xref>] also found a higher percentage of alleles &gt;40 CGGs in women with occult primary ovarian insufficiency. Karimov et al. [<xref ref-type="bibr" rid="B130-genes-07-00123">130</xref>] published similar results.</p>
<p>On the other hand, authors such as Bennett et al. [<xref ref-type="bibr" rid="B131-genes-07-00123">131</xref>], Murray et al. [<xref ref-type="bibr" rid="B132-genes-07-00123">132</xref>] or Voourhis et al. [<xref ref-type="bibr" rid="B133-genes-07-00123">133</xref>] did not find an association between <italic>FMR1</italic> intermediate alleles and primary ovarian insufficiency.</p>
</sec>
<sec id="sec4dot4-genes-07-00123">
<title>4.4. Molecular and Cellular Mechanisms</title>
<p>Molecular mechanisms that compromise follicular function are unknown but it is proposed that they can occur at various stages of follicular development and could be related to: an initial decrease in the ovarian reserve, altered recruitment of the follicle, increased atresia, or altered hypothalamic-pituitary-gonadal axis. FMRP is expressed in different areas that could affect these processes such as the brain and critic regions for hormonal regulation.</p>
<p>An important question is why the ovarian dysfunction is limited to premutation and intermediate carrier women, and it is not observed in full mutation carriers. The <italic>FMR1</italic>-mRNA levels are higher in premutation and intermediate carriers, so a direct or indirect effect of mRNA levels has been proposed, similar to that which occurs in FXTAS. Conway et al. [<xref ref-type="bibr" rid="B17-genes-07-00123">17</xref>] suggested a toxic effect of the elevated levels of <italic>FMR1</italic>-mRNA that can lead to a diminished ovarian reserve before birth. Later, Sullivan et al. [<xref ref-type="bibr" rid="B116-genes-07-00123">116</xref>] proposed that ovarian dysfunction associated to premutation and intermediate alleles could be considered a late age-of-onset disorder. The mRNA toxic effect leads to increased atresia or apoptosis of follicles.</p>
<p>Among female premutation carriers <italic>FMR1</italic>-mRNA levels do not seem to be parallel to the increase in CGG repeats [<xref ref-type="bibr" rid="B57-genes-07-00123">57</xref>,<xref ref-type="bibr" rid="B134-genes-07-00123">134</xref>,<xref ref-type="bibr" rid="B135-genes-07-00123">135</xref>]. This could be related with the non-linear association between premutation repeat size and risk for ovarian failure proposed previously by Ennis et al. [<xref ref-type="bibr" rid="B120-genes-07-00123">120</xref>].</p>
<p>Lu et al. [<xref ref-type="bibr" rid="B136-genes-07-00123">136</xref>] analyzed a premutation carrier mouse and observed that the mRNA increase was sufficient to cause a reduction in the follicle number leading to a deficient fertility. However, Hoffman et al. [<xref ref-type="bibr" rid="B137-genes-07-00123">137</xref>] found that development and establishment of primordial follicle pool was normal but there was an accelerated loss of follicles, suggesting an intrinsic problem of the ovary.</p>
<p>Investigations in humans have noted that FMRP is expressed in oocytes of fetal ovaries [<xref ref-type="bibr" rid="B138-genes-07-00123">138</xref>] and in granulose cells of mature follicles [<xref ref-type="bibr" rid="B135-genes-07-00123">135</xref>]. More recently, it has been shown that <italic>FMR1</italic>-mRNA levels are elevated in granulose cells and that these levels have not a lineal association with CGG repeats [<xref ref-type="bibr" rid="B139-genes-07-00123">139</xref>].</p>
<p>Some authors [<xref ref-type="bibr" rid="B135-genes-07-00123">135</xref>,<xref ref-type="bibr" rid="B140-genes-07-00123">140</xref>,<xref ref-type="bibr" rid="B141-genes-07-00123">141</xref>] consider FMRP and its expression in granulose cells a quantitative trait that controls ovarian reserve: during follicular maturation granulose cells express some genetically controlled endocrine signals and signaling pathways important for the correct maturation of oocytes. These signals could be reduced or disappear when <italic>FMR1</italic>-mRNA and FMRP (which act as translational repressors by binding to multiple transcripts and controlling their level of translation) are altered among premutation and intermediate carriers.</p>
<p>Therefore, elevated levels of <italic>FMR1</italic>-mRNA observed in women carrying intermediate and premutation alleles could give rise to an elevated toxicity that would lead to a higher atresia of the follicles [<xref ref-type="bibr" rid="B34-genes-07-00123">34</xref>] or to a reduction in the number of growing follicles like in the mouse model. In both cases the result would be diminished fertility.</p>
</sec>
</sec>
<sec id="sec5-genes-07-00123">
<title>5. Summary</title>
<p><italic>FMR1</italic> gene is one of the most important genes related to POI. For this reason, it is important to analyze <italic>FMR1</italic> gene among women presenting signs of ovarian dysfunction of unknown cause. This analysis must include the study of <italic>FMR1</italic> gene structure, including both CGG repeat number and AGG interruption pattern. This would be useful for knowing not only the etiology of ovarian dysfunction but also for detecting intermediate and premutation alleles that could expand in some generations leading to a mutation and consequently to a fragile X syndrome. Moreover, detection of these alleles among young women allows the genetic counseling necessary for planning their reproductive lives considering possible ovarian dysfunction. In relation to the molecular mechanisms, more research in humans is needed to elucidate how <italic>FMR1</italic>-mRNA and FMRP act in the ovaries.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>This work was supported by the Vice-rectorate for Research of the University of the Basque Country, Bilbao, Spain.</p>
</ack>
<notes>
<title>Author Contributions</title>
<p>M. Barasoain contributed primarily to the article; G. Barrenetxea, I. Huerta, M. Télez and B. Criado edited the paper; I. Arrieta edited the paper and is the corresponding author.</p>
</notes>
<notes notes-type="COI-statement">
<title>Conflicts of Interest</title>
<p>The authors declare no conflict of interest.</p>
</notes>
<ref-list>
<title>References</title>
<ref id="B1-genes-07-00123">
<label>1.</label>
<element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Sherman</surname><given-names>S.L.</given-names></name><name><surname>Taylor</surname><given-names>K.</given-names></name><name><surname>Allen</surname><given-names>E.</given-names></name></person-group>
<article-title>FMR1 premutation: A leading cause of inherited ovarian dysfunction</article-title>
<source/>Fragile Sites: New Discoveries and Changing Perspectives
<edition>1st ed.</edition>
<person-group person-group-type="editor"><name><surname>Arrieta</surname><given-names>I.</given-names></name><name><surname>Penagarikano</surname><given-names>O.</given-names></name><name><surname>Télez</surname><given-names>M.</given-names></name></person-group>
<publisher-name>Nova Science Publishers, Inc.</publisher-name>
<publisher-loc>New York, NY, USA</publisher-loc>
<year>2007</year>
<fpage>299</fpage>
<lpage>320</lpage>
</element-citation>
</ref>
<ref id="B2-genes-07-00123">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>McKinlay</surname><given-names>S.M.</given-names></name><name><surname>Brambilla</surname><given-names>D.J.</given-names></name><name><surname>Posner</surname><given-names>J.G.</given-names></name></person-group>
<article-title>The normal menopause transition</article-title>
<source/>Maturitas
<year>1992</year>
<volume>14</volume>
<fpage>103</fpage>
<lpage>115</lpage>
<pub-id pub-id-type="doi">10.1016/0378-5122(92)90003-M</pub-id>
<pub-id pub-id-type="pmid">1565019</pub-id></element-citation>
</ref>
<ref id="B3-genes-07-00123">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Álvarez-García</surname><given-names>E.</given-names></name><name><surname>Labandeira</surname><given-names>A.</given-names></name></person-group>
<article-title>Estudio bioquímico de la menopausia y la perimenopausia</article-title>
<source/>Ed. Cont. Lab. Clín. (SEQC)
<year>2010</year>
<volume>13</volume>
<fpage>76</fpage>
<lpage>93</lpage>
</element-citation>
</ref>
<ref id="B4-genes-07-00123">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Amanvermez</surname><given-names>R.</given-names></name><name><surname>Tosun</surname><given-names>M.</given-names></name></person-group>
<article-title>An update on ovarian aging and ovarian reserve tests</article-title>
<source/>Int. J. Fertil. Steril.
<year>2016</year>
<volume>9</volume>
<fpage>411</fpage>
<lpage>415</lpage>
<pub-id pub-id-type="pmid">26985328</pub-id></element-citation>
</ref>
<ref id="B5-genes-07-00123">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Harlow</surname><given-names>S.D.</given-names></name><name><surname>Gass</surname><given-names>M.</given-names></name><name><surname>Hall</surname><given-names>J.E.</given-names></name><name><surname>Lobo</surname><given-names>R.</given-names></name><name><surname>Maki</surname><given-names>P.</given-names></name><name><surname>Rebar</surname><given-names>R.W.</given-names></name><name><surname>Sherman</surname><given-names>S.</given-names></name><name><surname>Sluss</surname><given-names>P.M.</given-names></name><name><surname>de Villiers</surname><given-names>T.J.</given-names></name></person-group>
<article-title>MBChB, FRCOG, FCOG (SA), for the STRAW + 10 Collaborative Group. Executive summary of the Stages of Reproductive Aging Workshop + 10: Addressing the unfinished agenda of staging reproductive aging</article-title>
<source/>Menopause
<year>2012</year>
<volume>19</volume>
<fpage>387</fpage>
<lpage>395</lpage>
<pub-id pub-id-type="doi">10.1097/gme.0b013e31824d8f40</pub-id>
<pub-id pub-id-type="pmid">22343510</pub-id></element-citation>
</ref>
<ref id="B6-genes-07-00123">
<label>6.</label>
<element-citation publication-type="webpage">
<article-title>Spanish Association for the Study of Menopause, AEEM</article-title>
<comment>Available online: <ext-link ext-link-type="uri" xlink:href="http://www.aeem.es/">http://www.aeem.es/</ext-link></comment>
<date-in-citation>(accessed on 10 June 2016)</date-in-citation>
</element-citation>
</ref>
<ref id="B7-genes-07-00123">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Welt</surname><given-names>C.K.</given-names></name></person-group>
<article-title>Primary ovarian insufficiency: A more accurate term for premature ovarian failure</article-title>
<source/>Clin. Endocrinol.
<year>2008</year>
<volume>68</volume>
<fpage>499</fpage>
<lpage>509</lpage>
<pub-id pub-id-type="doi">10.1111/j.1365-2265.2007.03073.x</pub-id>
<pub-id pub-id-type="pmid">17970776</pub-id></element-citation>
</ref>
<ref id="B8-genes-07-00123">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>De Vos</surname><given-names>M.</given-names></name><name><surname>Devroey</surname><given-names>P.</given-names></name><name><surname>Fauser</surname><given-names>B.C.J.M.</given-names></name></person-group>
<article-title>Primary ovarian insufficiency</article-title>
<source/>Lancet
<year>2010</year>
<volume>376</volume>
<fpage>911</fpage>
<lpage>921</lpage>
<pub-id pub-id-type="doi">10.1016/S0140-6736(10)60355-8</pub-id>
<pub-id pub-id-type="pmid">20708256</pub-id></element-citation>
</ref>
<ref id="B9-genes-07-00123">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Panay</surname><given-names>N.</given-names></name><name><surname>Kalu</surname><given-names>E.</given-names></name></person-group>
<article-title>Management of premature ovarian failure</article-title>
<source/>Best Pract. Res. Clin. Obstet. Gynaecol.
<year>2009</year>
<volume>23</volume>
<fpage>129</fpage>
<lpage>140</lpage>
<pub-id pub-id-type="doi">10.1016/j.bpobgyn.2008.10.008</pub-id>
<pub-id pub-id-type="pmid">19091633</pub-id></element-citation>
</ref>
<ref id="B10-genes-07-00123">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Soave</surname><given-names>I.</given-names></name><name><surname>Lo Monte</surname><given-names>G.</given-names></name><name><surname>Marci</surname><given-names>R.</given-names></name></person-group>
<article-title>POI: Premature ovarian insufficiency/pregnancy or infertility?</article-title>
<source/>N. Am. J. Med. Sci.
<year>2013</year>
<volume>5</volume>
<fpage>71</fpage>
<pub-id pub-id-type="pmid">23378962</pub-id></element-citation>
</ref>
<ref id="B11-genes-07-00123">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Allen</surname><given-names>E.G.</given-names></name><name><surname>Grus</surname><given-names>W.E.</given-names></name><name><surname>Narayan</surname><given-names>S.</given-names></name><name><surname>Espinel</surname><given-names>W.</given-names></name><name><surname>Sherman</surname><given-names>S.L.</given-names></name></person-group>
<article-title>Approaches to identify genetic variants that influence the risk for onset of fragile X-associated primary ovarian insufficiency (FXPOI): A preliminary study</article-title>
<source/>Front. Genet.
<year>2014</year>
<volume>5</volume>
<fpage>260</fpage>
<pub-id pub-id-type="doi">10.3389/fgene.2014.00260</pub-id>
<pub-id pub-id-type="pmid">25147555</pub-id></element-citation>
</ref>
<ref id="B12-genes-07-00123">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sherman</surname><given-names>S.L.</given-names></name><name><surname>Curnow</surname><given-names>E.C.</given-names></name><name><surname>Easley</surname><given-names>C.A.</given-names></name><name><surname>Jin</surname><given-names>P.</given-names></name><name><surname>Hukema</surname><given-names>R.K.</given-names></name><name><surname>Tejada</surname><given-names>M.I.</given-names></name><name><surname>Willemsen</surname><given-names>R.</given-names></name><name><surname>Usdin</surname><given-names>K.</given-names></name></person-group>
<article-title>Use of model systems to understand the etiology of fragile X-associated primary ovarian insufficiency (FXPOI)</article-title>
<source/>J. Neurodev. Disord.
<year>2014</year>
<volume>6</volume>
<fpage>26</fpage>
<pub-id pub-id-type="doi">10.1186/1866-1955-6-26</pub-id>
<pub-id pub-id-type="pmid">25147583</pub-id></element-citation>
</ref>
<ref id="B13-genes-07-00123">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hewlett</surname><given-names>M.</given-names></name><name><surname>Mahalingaiah</surname><given-names>S.</given-names></name></person-group>
<article-title>Update on primary ovarian insufficiency</article-title>
<source/>Curr. Opin. Endocrinol. Diabetes Obes.
<year>2015</year>
<volume>22</volume>
<fpage>483</fpage>
<lpage>489</lpage>
<pub-id pub-id-type="doi">10.1097/MED.0000000000000206</pub-id>
<pub-id pub-id-type="pmid">26512773</pub-id></element-citation>
</ref>
<ref id="B14-genes-07-00123">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Daan</surname><given-names>N.</given-names></name><name><surname>Hoek</surname><given-names>A.</given-names></name><name><surname>Corpeleijn</surname><given-names>E.</given-names></name><name><surname>Eijkemans</surname><given-names>M.J.C.</given-names></name><name><surname>Broekmans</surname><given-names>F.J.</given-names></name><name><surname>Fauser</surname><given-names>B.C.J.M.</given-names></name><name><surname>Koster</surname><given-names>M.P.H.</given-names></name></person-group>
<article-title>Reproductive characteristics of women diagnosed with premature ovarian insufficiency</article-title>
<source/>Reprod. Biomed. Online
<year>2016</year>
<volume>32</volume>
<fpage>225</fpage>
<lpage>232</lpage>
<pub-id pub-id-type="doi">10.1016/j.rbmo.2015.11.009</pub-id>
<pub-id pub-id-type="pmid">26680028</pub-id></element-citation>
</ref>
<ref id="B15-genes-07-00123">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Qin</surname><given-names>Y.</given-names></name><name><surname>Jiao</surname><given-names>X.</given-names></name><name><surname>Simpson</surname><given-names>J.L.</given-names></name><name><surname>Chen</surname><given-names>Z.-J.</given-names></name></person-group>
<article-title>Genetics of primary ovarian insufficiency: New developments and opportunities</article-title>
<source/>Hum. Reprod. Update
<year>2015</year>
<volume>21</volume>
<fpage>787</fpage>
<lpage>808</lpage>
<pub-id pub-id-type="doi">10.1093/humupd/dmv036</pub-id>
<pub-id pub-id-type="pmid">26243799</pub-id></element-citation>
</ref>
<ref id="B16-genes-07-00123">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fortuño</surname><given-names>C.</given-names></name><name><surname>Labarta</surname><given-names>E.</given-names></name></person-group>
<article-title>Genetics of primary ovarian insufficiency: A review</article-title>
<source/>J. Assist. Reprod. Genet.
<year>2014</year>
<volume>31</volume>
<fpage>1573</fpage>
<lpage>1585</lpage>
<pub-id pub-id-type="doi">10.1007/s10815-014-0342-9</pub-id>
<pub-id pub-id-type="pmid">25227694</pub-id></element-citation>
</ref>
<ref id="B17-genes-07-00123">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Conway</surname><given-names>G.S.</given-names></name><name><surname>Hettiarachchi</surname><given-names>S.</given-names></name><name><surname>Murray</surname><given-names>A.</given-names></name><name><surname>Jacobs</surname><given-names>P.A.</given-names></name></person-group>
<article-title>Fragile X premutations in familial premature ovarian failure</article-title>
<source/>Lancet
<year>1995</year>
<volume>346</volume>
<fpage>309</fpage>
<lpage>310</lpage>
<pub-id pub-id-type="doi">10.1016/S0140-6736(95)92194-X</pub-id>
<pub-id pub-id-type="pmid">7630263</pub-id></element-citation>
</ref>
<ref id="B18-genes-07-00123">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sherman</surname><given-names>S.L.</given-names></name></person-group>
<article-title>Premature ovarian failure in the fragile X syndrome</article-title>
<source/>Am. J. Med. Genet.
<year>2000</year>
<volume>97</volume>
<fpage>189</fpage>
<lpage>194</lpage>
<pub-id pub-id-type="doi">10.1002/1096-8628(200023)97:3&lt;189::AID-AJMG1036&gt;3.0.CO;2-J</pub-id>
<pub-id pub-id-type="pmid">11449487</pub-id></element-citation>
</ref>
<ref id="B19-genes-07-00123">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pouresmaeili</surname><given-names>F.</given-names></name><name><surname>Fazeli</surname><given-names>Z.</given-names></name></person-group>
<article-title>Premature ovarian failure: A critical condition in the reproductive potential with various genetic causes</article-title>
<source/>Int. J. Fertil. Steril.
<year>2014</year>
<volume>8</volume>
<fpage>1</fpage>
<lpage>12</lpage>
<pub-id pub-id-type="pmid">24696764</pub-id></element-citation>
</ref>
<ref id="B20-genes-07-00123">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Murray</surname><given-names>A.</given-names></name><name><surname>Webb</surname><given-names>J.</given-names></name><name><surname>Grimley</surname><given-names>S.</given-names></name><name><surname>Conway</surname><given-names>G.S.</given-names></name><name><surname>Jacobs</surname><given-names>P.</given-names></name></person-group>
<article-title>Studies of FRAXA and FRAXE in women with premature ovarian failure</article-title>
<source/>J. Med. Genet.
<year>1998</year>
<volume>35</volume>
<fpage>637</fpage>
<lpage>640</lpage>
<pub-id pub-id-type="doi">10.1136/jmg.35.8.637</pub-id>
<pub-id pub-id-type="pmid">9719368</pub-id></element-citation>
</ref>
<ref id="B21-genes-07-00123">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Su</surname><given-names>Y.Q.</given-names></name><name><surname>Wu</surname><given-names>X.</given-names></name><name><surname>O’Brien</surname><given-names>M.J.</given-names></name><name><surname>Pendola</surname><given-names>F.L.</given-names></name><name><surname>Denegre</surname><given-names>J.N.</given-names></name><name><surname>Matzuk</surname><given-names>M.M.</given-names></name><name><surname>Eppig</surname><given-names>J.J.</given-names></name></person-group>
<article-title>Synergistic roles of BMP15 and GDF9 in the development and function of the oocyte-cumulus cell complex in mice: Genetic evidence for an oocyte-granulosa cell regulatory loop</article-title>
<source/>Dev. Biol.
<year>2004</year>
<volume>276</volume>
<fpage>64</fpage>
<lpage>73</lpage>
<pub-id pub-id-type="doi">10.1016/j.ydbio.2004.08.020</pub-id>
<pub-id pub-id-type="pmid">15531364</pub-id></element-citation>
</ref>
<ref id="B22-genes-07-00123">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>McNatty</surname><given-names>K.P.</given-names></name><name><surname>Juengel</surname><given-names>J.L.</given-names></name><name><surname>Reader</surname><given-names>K.L.</given-names></name><name><surname>Lun</surname><given-names>S.</given-names></name><name><surname>Myllymaa</surname><given-names>S.</given-names></name><name><surname>Lawrence</surname><given-names>S.B.</given-names></name><name><surname>Western</surname><given-names>A.</given-names></name><name><surname>Meerasahib</surname><given-names>M.F.</given-names></name><name><surname>Mottershead</surname><given-names>D.G.</given-names></name><name><surname>Groome</surname><given-names>N.P.</given-names></name><etal></etal></person-group>
<article-title>Bone morphogenetic protein 15 and growth differentiation factor 9 co-operate to regulate granulosa cell function in ruminants</article-title>
<source/>Reproduction
<year>2005</year>
<volume>129</volume>
<fpage>481</fpage>
<lpage>487</lpage>
<pub-id pub-id-type="doi">10.1530/rep.1.00517</pub-id>
<pub-id pub-id-type="pmid">15798023</pub-id></element-citation>
</ref>
<ref id="B23-genes-07-00123">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Palmer</surname><given-names>J.S.</given-names></name><name><surname>Zhao</surname><given-names>Z.Z.</given-names></name><name><surname>Hoekstra</surname><given-names>C.</given-names></name><name><surname>Hayward</surname><given-names>N.K.</given-names></name><name><surname>Webb</surname><given-names>P.M.</given-names></name><name><surname>Whiteman</surname><given-names>D.C.</given-names></name><name><surname>Martin</surname><given-names>N.G.</given-names></name><name><surname>Boomsma</surname><given-names>D.I.</given-names></name><name><surname>Duffy</surname><given-names>D.L.</given-names></name><name><surname>Montgomery</surname><given-names>G.W.</given-names></name></person-group>
<article-title>Novel variants in growth differentiation factor 9 in mothers of dizygotic twins</article-title>
<source/>J. Clin. Endocrinol. Metab.
<year>2006</year>
<volume>91</volume>
<fpage>4713</fpage>
<lpage>4716</lpage>
<pub-id pub-id-type="doi">10.1210/jc.2006-0970</pub-id>
<pub-id pub-id-type="pmid">16954162</pub-id></element-citation>
</ref>
<ref id="B24-genes-07-00123">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Caburet</surname><given-names>S.</given-names></name><name><surname>Arboleda</surname><given-names>V.A.</given-names></name><name><surname>Llano</surname><given-names>E.</given-names></name><name><surname>Overbeek</surname><given-names>P.A.</given-names></name><name><surname>Barbero</surname><given-names>J.L.</given-names></name><name><surname>Oka</surname><given-names>K.</given-names></name><name><surname>Harrison</surname><given-names>W.</given-names></name><name><surname>Vaiman</surname><given-names>D.</given-names></name><name><surname>Ben-Neriah</surname><given-names>Z.</given-names></name><name><surname>García-Tuñón</surname><given-names>I.</given-names></name><etal></etal></person-group>
<article-title>Mutant cohesin in premature ovarian failure</article-title>
<source/>N. Engl. J. Med.
<year>2014</year>
<volume>370</volume>
<fpage>943</fpage>
<lpage>949</lpage>
<pub-id pub-id-type="doi">10.1056/NEJMoa1309635</pub-id>
<pub-id pub-id-type="pmid">24597867</pub-id></element-citation>
</ref>
<ref id="B25-genes-07-00123">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Llano</surname><given-names>E.</given-names></name><name><surname>Gómez-H</surname><given-names>L.</given-names></name><name><surname>GarcÍa-Tuñón</surname><given-names>I.</given-names></name><name><surname>Sánchez-Martín</surname><given-names>M.</given-names></name><name><surname>Caburet</surname><given-names>S.</given-names></name><name><surname>Barbero</surname><given-names>J.L.</given-names></name><name><surname>Schimenti</surname><given-names>J.C.</given-names></name><name><surname>Veitia</surname><given-names>R.A.</given-names></name><name><surname>Pendas</surname><given-names>A.M.</given-names></name></person-group>
<article-title>STAG3 is a strong candidate gene for male infertility. Human Molecular Genetics</article-title>
<source/>Hum. Mol. Genet.
<year>2014</year>
<volume>23</volume>
<fpage>3421</fpage>
<lpage>3431</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/ddu051</pub-id>
<pub-id pub-id-type="pmid">24608227</pub-id></element-citation>
</ref>
<ref id="B26-genes-07-00123">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bachelot</surname><given-names>A.</given-names></name><name><surname>Rouxel</surname><given-names>A.</given-names></name><name><surname>Massin</surname><given-names>N.</given-names></name><name><surname>Dulon</surname><given-names>J.</given-names></name><name><surname>Courtillot</surname><given-names>C.</given-names></name><name><surname>Matuchansky</surname><given-names>C.</given-names></name><name><surname>Badachi</surname><given-names>Y.</given-names></name><name><surname>Fortin</surname><given-names>A.</given-names></name><name><surname>Paniel</surname><given-names>B.</given-names></name><name><surname>Lecuru</surname><given-names>F.</given-names></name><etal></etal></person-group>
<article-title>Phenotyping and genetic studies of 357 consecutive patients presenting with premature ovarian failure</article-title>
<source/>Eur. J. Endocrinol.
<year>2009</year>
<volume>161</volume>
<fpage>179</fpage>
<lpage>187</lpage>
<pub-id pub-id-type="doi">10.1530/EJE-09-0231</pub-id>
<pub-id pub-id-type="pmid">19411303</pub-id></element-citation>
</ref>
<ref id="B27-genes-07-00123">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jin</surname><given-names>M.</given-names></name><name><surname>YiQi</surname><given-names>Y.</given-names></name><name><surname>Hefeng</surname><given-names>H.</given-names></name></person-group>
<article-title>An update on primary ovarian insufficiency</article-title>
<source/>Sci. China Life Sci.
<year>2012</year>
<volume>55</volume>
<fpage>677</fpage>
<lpage>686</lpage>
<pub-id pub-id-type="doi">10.1007/s11427-012-4355-2</pub-id>
<pub-id pub-id-type="pmid">22932883</pub-id></element-citation>
</ref>
<ref id="B28-genes-07-00123">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Forges</surname><given-names>T.</given-names></name><name><surname>Monnier-Barbarino</surname><given-names>P.</given-names></name><name><surname>Faure</surname><given-names>G.C.</given-names></name><name><surname>Bene</surname><given-names>M.C.</given-names></name></person-group>
<article-title>Autoinmunity and antigenic targets in ovarian pathology</article-title>
<source/>Hum. Reprod. Update
<year>2004</year>
<volume>10</volume>
<fpage>163</fpage>
<lpage>175</lpage>
<pub-id pub-id-type="doi">10.1093/humupd/dmh014</pub-id>
<pub-id pub-id-type="pmid">15073145</pub-id></element-citation>
</ref>
<ref id="B29-genes-07-00123">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Goswami</surname><given-names>R.</given-names></name><name><surname>Marwaha</surname><given-names>R.K.</given-names></name><name><surname>Goswami</surname><given-names>D.</given-names></name><name><surname>Gupta</surname><given-names>N.</given-names></name><name><surname>Ray</surname><given-names>D.</given-names></name><name><surname>Tomar</surname><given-names>N.</given-names></name><name><surname>Singh</surname><given-names>S.</given-names></name></person-group>
<article-title>Prevalence of thyroid autoimmunity in sporadic idiopathic hypoparathyroidism in comparison to type I diabetes and premature ovarian failure</article-title>
<source/>J. Clin. Endocrinol. Metab.
<year>2006</year>
<volume>91</volume>
<fpage>4256</fpage>
<lpage>4259</lpage>
<pub-id pub-id-type="doi">10.1210/jc.2006-1005</pub-id>
<pub-id pub-id-type="pmid">16895958</pub-id></element-citation>
</ref>
<ref id="B30-genes-07-00123">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cox</surname><given-names>L.</given-names></name><name><surname>Liu</surname><given-names>J.H.</given-names></name></person-group>
<article-title>Primary ovarian insufficiency: An update</article-title>
<source/>Int. J. Womens Health
<year>2014</year>
<volume>6</volume>
<fpage>235</fpage>
<lpage>243</lpage>
<pub-id pub-id-type="pmid">24591848</pub-id></element-citation>
</ref>
<ref id="B31-genes-07-00123">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Verkerk</surname><given-names>A.J.M.</given-names></name><name><surname>Pieretti</surname><given-names>M.</given-names></name><name><surname>Sutcliffe</surname><given-names>J.S.</given-names></name><name><surname>Fu</surname><given-names>Y.H.</given-names></name><name><surname>Kuhl</surname><given-names>D.P.A.</given-names></name><name><surname>Pizzuti</surname><given-names>A.</given-names></name><name><surname>Reiner</surname><given-names>O.</given-names></name><name><surname>Richards</surname><given-names>S.</given-names></name><name><surname>Victoria</surname><given-names>M.F.</given-names></name><name><surname>Zhang</surname><given-names>F.</given-names></name><etal></etal></person-group>
<article-title>Identification of a gene FMR-1 containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome</article-title>
<source/>Cell
<year>1991</year>
<volume>65</volume>
<fpage>905</fpage>
<lpage>914</lpage>
<pub-id pub-id-type="doi">10.1016/0092-8674(91)90397-H</pub-id>
<pub-id pub-id-type="pmid">1710175</pub-id></element-citation>
</ref>
<ref id="B32-genes-07-00123">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yu</surname><given-names>S.</given-names></name><name><surname>Pritchard</surname><given-names>M.</given-names></name><name><surname>Kremer</surname><given-names>E.</given-names></name><name><surname>Lynch</surname><given-names>M.</given-names></name><name><surname>Nancarrow</surname><given-names>J.</given-names></name><name><surname>Baker</surname><given-names>E.</given-names></name><name><surname>Holman</surname><given-names>K.</given-names></name><name><surname>Mulley</surname><given-names>J.C.</given-names></name><name><surname>Warren</surname><given-names>S.T.</given-names></name><name><surname>Schlessinger</surname><given-names>D.</given-names></name><etal></etal></person-group>
<article-title>Fragile X genotype characterized by an unstable region of DNA</article-title>
<source/>Science
<year>1991</year>
<volume>252</volume>
<fpage>1179</fpage>
<lpage>1181</lpage>
<pub-id pub-id-type="doi">10.1126/science.252.5009.1179</pub-id>
<pub-id pub-id-type="pmid">2031189</pub-id></element-citation>
</ref>
<ref id="B33-genes-07-00123">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Oberlé</surname><given-names>I.</given-names></name><name><surname>Rousseau</surname><given-names>F.</given-names></name><name><surname>Heitz</surname><given-names>D.</given-names></name><name><surname>Kretz</surname><given-names>C.</given-names></name><name><surname>Devys</surname><given-names>D.</given-names></name><name><surname>Hanauer</surname><given-names>A.</given-names></name><name><surname>Boué</surname><given-names>J.</given-names></name><name><surname>Bertheas</surname><given-names>M.F.</given-names></name><name><surname>Mandel</surname><given-names>J.L.</given-names></name></person-group>
<article-title>Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome</article-title>
<source/>Science
<year>1991</year>
<volume>252</volume>
<fpage>1097</fpage>
<lpage>1102</lpage>
<pub-id pub-id-type="doi">10.1126/science.252.5009.1097</pub-id>
<pub-id pub-id-type="pmid">2031184</pub-id></element-citation>
</ref>
<ref id="B34-genes-07-00123">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Willemsen</surname><given-names>R.</given-names></name><name><surname>Levenga</surname><given-names>J.</given-names></name><name><surname>Oostra</surname><given-names>B.A.</given-names></name></person-group>
<article-title>CGG repeat in the FMR1 gene: Size matters</article-title>
<source/>Clin. Genet.
<year>2011</year>
<volume>80</volume>
<fpage>214</fpage>
<lpage>225</lpage>
<pub-id pub-id-type="doi">10.1111/j.1399-0004.2011.01723.x</pub-id>
<pub-id pub-id-type="pmid">21651511</pub-id></element-citation>
</ref>
<ref id="B35-genes-07-00123">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Eichler</surname><given-names>E.E.</given-names></name><name><surname>Richards</surname><given-names>S.</given-names></name><name><surname>Gibbs</surname><given-names>R.A.</given-names></name><name><surname>Nelson</surname><given-names>D.L.</given-names></name></person-group>
<article-title>Fine structure of the human FMR1 gene</article-title>
<source/>Hum. Mol. Genet.
<year>1993</year>
<volume>2</volume>
<fpage>1147</fpage>
<lpage>1153</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/2.8.1147</pub-id>
<pub-id pub-id-type="pmid">8401496</pub-id></element-citation>
</ref>
<ref id="B36-genes-07-00123">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Snow</surname><given-names>K.</given-names></name><name><surname>Doud</surname><given-names>L.K.</given-names></name><name><surname>Hagerman</surname><given-names>R.</given-names></name><name><surname>Pergolizzi</surname><given-names>R.G.</given-names></name><name><surname>Erster</surname><given-names>S.H.</given-names></name><name><surname>Thibideau</surname><given-names>S.N.</given-names></name></person-group>
<article-title>Analysis of a CGG sequence at the FMR1 locus in fragile X families and the general population</article-title>
<source/>Am. J. Hum. Genet.
<year>1993</year>
<volume>53</volume>
<fpage>1217</fpage>
<lpage>1228</lpage>
<pub-id pub-id-type="pmid">7902673</pub-id></element-citation>
</ref>
<ref id="B37-genes-07-00123">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Larsen</surname><given-names>L.A.</given-names></name><name><surname>Gronskov</surname><given-names>K.</given-names></name><name><surname>Norgaard-Pedersen</surname><given-names>B.</given-names></name><name><surname>Brondum-Nielsen</surname><given-names>K.</given-names></name><name><surname>Hasholt</surname><given-names>L.</given-names></name><name><surname>Vuust</surname><given-names>J.</given-names></name></person-group>
<article-title>High-throughput analysis of fragile X (CGG)n alleles in the normal and premutation range by PCR amplification and automated capillary electrophoresis</article-title>
<source/>Hum. Genet.
<year>1997</year>
<volume>100</volume>
<fpage>564</fpage>
<lpage>568</lpage>
<pub-id pub-id-type="doi">10.1007/s004390050552</pub-id>
<pub-id pub-id-type="pmid">9341871</pub-id></element-citation>
</ref>
<ref id="B38-genes-07-00123">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Patsalis</surname><given-names>P.C.</given-names></name><name><surname>Sismani</surname><given-names>C.</given-names></name><name><surname>Hettinger</surname><given-names>J.A.</given-names></name><name><surname>Holden</surname><given-names>J.</given-names></name><name><surname>Lawson</surname><given-names>J.S.</given-names></name><name><surname>Chalifoux</surname><given-names>M.</given-names></name><name><surname>Wing</surname><given-names>M.</given-names></name><name><surname>Walker</surname><given-names>M.</given-names></name><name><surname>Leggo</surname><given-names>J.</given-names></name></person-group>
<article-title>Frequencies of “grey zone” and premutation size FMR1 CGG-repeat alleles in patients with developmental disability in Cyprus and Canada</article-title>
<source/>Am. J. Med. Genet.
<year>1999</year>
<volume>84</volume>
<fpage>195</fpage>
<lpage>197</lpage>
<pub-id pub-id-type="doi">10.1002/(SICI)1096-8628(19990528)84:3&lt;195::AID-AJMG4&gt;3.0.CO;2-1</pub-id>
<pub-id pub-id-type="pmid">10331589</pub-id></element-citation>
</ref>
<ref id="B39-genes-07-00123">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dombrowski</surname><given-names>C.</given-names></name><name><surname>Levesque</surname><given-names>M.L.</given-names></name><name><surname>Morel</surname><given-names>M.L.</given-names></name><name><surname>Rouillard</surname><given-names>P.</given-names></name><name><surname>Morgan</surname><given-names>K.</given-names></name><name><surname>Rousseau</surname><given-names>F.</given-names></name></person-group>
<article-title>Premutation and intermediate-size FMR1 alleles in 10,572 males from the general population: Loss of an AGG interruption is a late event in the generation of fragile X syndrome alleles</article-title>
<source/>Hum. Mol. Genet.
<year>2002</year>
<volume>11</volume>
<fpage>371</fpage>
<lpage>378</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/11.4.371</pub-id>
<pub-id pub-id-type="pmid">11854169</pub-id></element-citation>
</ref>
<ref id="B40-genes-07-00123">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hagerman</surname><given-names>P.J.</given-names></name></person-group>
<article-title>The fragile X prevalence paradox</article-title>
<source/>J. Med. Genet.
<year>2008</year>
<volume>45</volume>
<fpage>498</fpage>
<lpage>499</lpage>
<pub-id pub-id-type="doi">10.1136/jmg.2008.059055</pub-id>
<pub-id pub-id-type="pmid">18413371</pub-id></element-citation>
</ref>
<ref id="B41-genes-07-00123">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tassone</surname><given-names>F.</given-names></name></person-group>
<article-title>Newborn screening for fragile X syndrome</article-title>
<source/>JAMA Neurol.
<year>2014</year>
<volume>71</volume>
<fpage>355</fpage>
<lpage>359</lpage>
<pub-id pub-id-type="doi">10.1001/jamaneurol.2013.4808</pub-id>
<pub-id pub-id-type="pmid">24395328</pub-id></element-citation>
</ref>
<ref id="B42-genes-07-00123">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hill</surname><given-names>M.K.</given-names></name><name><surname>Archibald</surname><given-names>A.D.</given-names></name><name><surname>Cohen</surname><given-names>J.</given-names></name><name><surname>Metcalfe</surname><given-names>S.A.</given-names></name></person-group>
<article-title>A systematic review of population screening for fragile X syndrome</article-title>
<source/>Genet. Med.
<year>2010</year>
<volume>12</volume>
<fpage>396</fpage>
<lpage>410</lpage>
<pub-id pub-id-type="doi">10.1097/GIM.0b013e3181e38fb6</pub-id>
<pub-id pub-id-type="pmid">20548240</pub-id></element-citation>
</ref>
<ref id="B43-genes-07-00123">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Monaghan</surname><given-names>K.G.</given-names></name><name><surname>Lyon</surname><given-names>E.</given-names></name><name><surname>Spector</surname><given-names>E.B.</given-names></name><collab>American College of Medical Genetics and Genomics</collab></person-group>
<article-title>ACMG Standards and Guidelines for fragile X testing: A revision to the disease-specific supplements to the Standards and Guidelines for Clinical Genetics Laboratories of the American College of Medical Genetics and Genomics</article-title>
<source/>Genet. Med.
<year>2013</year>
<volume>15</volume>
<fpage>575</fpage>
<lpage>586</lpage>
<pub-id pub-id-type="doi">10.1038/gim.2013.61</pub-id>
<pub-id pub-id-type="pmid">23765048</pub-id></element-citation>
</ref>
<ref id="B44-genes-07-00123">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Genereux</surname><given-names>D.P.</given-names></name><name><surname>Laird</surname><given-names>C.D.</given-names></name></person-group>
<article-title>Why do fragile X carrier frequencies differ between Asian and non-Asian populations?</article-title>
<source/>Genes Genet. Syst.
<year>2013</year>
<volume>88</volume>
<fpage>211</fpage>
<lpage>224</lpage>
<pub-id pub-id-type="doi">10.1266/ggs.88.211</pub-id>
<pub-id pub-id-type="pmid">24025249</pub-id></element-citation>
</ref>
<ref id="B45-genes-07-00123">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pastore</surname><given-names>L.M.</given-names></name><name><surname>Manichaikul</surname><given-names>A.</given-names></name><name><surname>Wang</surname><given-names>X.Q.</given-names></name><name><surname>Finkelstein</surname><given-names>J.S.</given-names></name></person-group>
<article-title>FMR1 CGG Repeats: Reference Levels and Race-Ethnic Variation in Women with Normal Fertility (Study of Women’s Health Across the Nation)</article-title>
<source/>Reprod. Sci.
<year>2016</year>
<volume>23</volume>
<fpage>1225</fpage>
<lpage>1233</lpage>
<pub-id pub-id-type="doi">10.1177/1933719116632927</pub-id>
<pub-id pub-id-type="pmid">26905421</pub-id></element-citation>
</ref>
<ref id="B46-genes-07-00123">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Warren</surname><given-names>S.T.</given-names></name></person-group>
<article-title>The Epigenetics of fragile X syndrome</article-title>
<source/>Cell Stem Cell
<year>2007</year>
<volume>1</volume>
<fpage>488</fpage>
<lpage>489</lpage>
<pub-id pub-id-type="doi">10.1016/j.stem.2007.10.017</pub-id>
<pub-id pub-id-type="pmid">18938744</pub-id></element-citation>
</ref>
<ref id="B47-genes-07-00123">
<label>47.</label>
<element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Peñagarikano</surname><given-names>O.</given-names></name><name><surname>Warren</surname><given-names>S.T.</given-names></name></person-group>
<article-title>FRAXA: The fragile X syndrome site</article-title>
<source/>Fragile Sites: New Discoveries and Changing Perspectives
<edition>1st ed.</edition>
<person-group person-group-type="editor"><name><surname>Arrieta</surname><given-names>I.</given-names></name><name><surname>Penagarikano</surname><given-names>O.</given-names></name><name><surname>Télez</surname><given-names>M.</given-names></name></person-group>
<publisher-name>Nova Science Publishers, Inc.</publisher-name>
<publisher-loc>New York, NY, USA</publisher-loc>
<year>2007</year>
<fpage>283</fpage>
<lpage>298</lpage>
</element-citation>
</ref>
<ref id="B48-genes-07-00123">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pietrobono</surname><given-names>R.</given-names></name><name><surname>Tabolacci</surname><given-names>E.</given-names></name><name><surname>Zalfa</surname><given-names>F.</given-names></name><name><surname>Zito</surname><given-names>I.</given-names></name><name><surname>Terracciano</surname><given-names>A.</given-names></name><name><surname>Moscato</surname><given-names>U.</given-names></name><name><surname>Bagni</surname><given-names>C.</given-names></name><name><surname>Oostra</surname><given-names>B.</given-names></name><name><surname>Chiurazzi</surname><given-names>P.</given-names></name><name><surname>Neri</surname><given-names>G.</given-names></name></person-group>
<article-title>Molecular dissection of the events leading to inactivation of the FMR1 gene</article-title>
<source/>Hum. Mol. Genet.
<year>2005</year>
<volume>14</volume>
<fpage>267</fpage>
<lpage>277</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/ddi024</pub-id>
<pub-id pub-id-type="pmid">15563507</pub-id></element-citation>
</ref>
<ref id="B49-genes-07-00123">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pietrobono</surname><given-names>R.</given-names></name><name><surname>Pomponi</surname><given-names>M.G.</given-names></name><name><surname>Tabolacci</surname><given-names>E.</given-names></name><name><surname>Oostra</surname><given-names>B.</given-names></name><name><surname>Chiurazzi</surname><given-names>P.</given-names></name><name><surname>Neri</surname><given-names>G.</given-names></name></person-group>
<article-title>Quantitative analysis of DNA demethylation and transcriptional reactivation of the FMR1 gene in fragile X cells treated with 5-azadeoxycytidine</article-title>
<source/>Nucleic Acids Res.
<year>2002</year>
<volume>30</volume>
<fpage>3278</fpage>
<lpage>3285</lpage>
<pub-id pub-id-type="doi">10.1093/nar/gkf434</pub-id>
<pub-id pub-id-type="pmid">12136110</pub-id></element-citation>
</ref>
<ref id="B50-genes-07-00123">
<label>50.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Oostra</surname><given-names>B.A.</given-names></name><name><surname>Willemsen</surname><given-names>R.</given-names></name></person-group>
<article-title>FMR1: A gene with three faces</article-title>
<source/>Biochim. Biophys. Acta
<year>2009</year>
<volume>1790</volume>
<fpage>467</fpage>
<lpage>477</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbagen.2009.02.007</pub-id>
<pub-id pub-id-type="pmid">19233246</pub-id></element-citation>
</ref>
<ref id="B51-genes-07-00123">
<label>51.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pearson</surname><given-names>C.E.</given-names></name><name><surname>Edamura</surname><given-names>K.N.</given-names></name><name><surname>Cleary</surname><given-names>J.G.</given-names></name></person-group>
<article-title>Repeat instability: Mechanisms of dynamic mutations</article-title>
<source/>Nat. Rev. Genet.
<year>2005</year>
<volume>6</volume>
<fpage>729</fpage>
<lpage>742</lpage>
<pub-id pub-id-type="doi">10.1038/nrg1689</pub-id>
<pub-id pub-id-type="pmid">16205713</pub-id></element-citation>
</ref>
<ref id="B52-genes-07-00123">
<label>52.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Brouwer</surname><given-names>J.R.</given-names></name><name><surname>Willemsen</surname><given-names>R.</given-names></name><name><surname>Oostra</surname><given-names>B.A.</given-names></name></person-group>
<article-title>Microsatellite repeat instability and neurological disease</article-title>
<source/>BioEssays
<year>2009</year>
<volume>31</volume>
<fpage>71</fpage>
<lpage>83</lpage>
<pub-id pub-id-type="doi">10.1002/bies.080122</pub-id>
<pub-id pub-id-type="pmid">19154005</pub-id></element-citation>
</ref>
<ref id="B53-genes-07-00123">
<label>53.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Terracciano</surname><given-names>A.</given-names></name><name><surname>Pomponi</surname><given-names>M.G.</given-names></name><name><surname>Marino</surname><given-names>G.M.</given-names></name><name><surname>Chiurazzi</surname><given-names>P.</given-names></name><name><surname>Rinaldi</surname><given-names>M.M.</given-names></name><name><surname>Dobosz</surname><given-names>M.</given-names></name><name><surname>Neri</surname><given-names>G.</given-names></name></person-group>
<article-title>Expansion to full mutation of a FMR1 intermediate allele over two generations</article-title>
<source/>Eur. J. Hum. Genet.
<year>2004</year>
<volume>12</volume>
<fpage>333</fpage>
<lpage>336</lpage>
<pub-id pub-id-type="doi">10.1038/sj.ejhg.5201154</pub-id>
<pub-id pub-id-type="pmid">14735162</pub-id></element-citation>
</ref>
<ref id="B54-genes-07-00123">
<label>54.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zuñiga</surname><given-names>A.</given-names></name><name><surname>Juan</surname><given-names>J.</given-names></name><name><surname>Milá</surname><given-names>M.</given-names></name><name><surname>Guerrero</surname><given-names>A.</given-names></name></person-group>
<article-title>Expansion of an intermediate allele of the FMR1 gene in only two generations</article-title>
<source/>Clin. Genet.
<year>2005</year>
<volume>68</volume>
<fpage>471</fpage>
<lpage>473</lpage>
<pub-id pub-id-type="doi">10.1111/j.1399-0004.2005.00514.x</pub-id>
<pub-id pub-id-type="pmid">16207218</pub-id></element-citation>
</ref>
<ref id="B55-genes-07-00123">
<label>55.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fernández-Carvajal</surname><given-names>I.</given-names></name><name><surname>López Posadas</surname><given-names>B.</given-names></name><name><surname>Pan</surname><given-names>R.</given-names></name><name><surname>Raske</surname><given-names>C.</given-names></name><name><surname>Hagerman</surname><given-names>P.J.</given-names></name><name><surname>Tassone</surname><given-names>F.</given-names></name></person-group>
<article-title>Expansion of an FMR1 grey-zone allele to a full mutation in two generations</article-title>
<source/>J. Mol. Diagn.
<year>2009</year>
<volume>11</volume>
<fpage>306</fpage>
<lpage>310</lpage>
<pub-id pub-id-type="doi">10.2353/jmoldx.2009.080174</pub-id>
<pub-id pub-id-type="pmid">19525339</pub-id></element-citation>
</ref>
<ref id="B56-genes-07-00123">
<label>56.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nolin</surname><given-names>S.L.</given-names></name><name><surname>Brown</surname><given-names>W.T.</given-names></name><name><surname>Glicksman</surname><given-names>A.</given-names></name><name><surname>Houck</surname><given-names>G.E.</given-names><suffix>Jr.</suffix></name><name><surname>Gargano</surname><given-names>A.D.</given-names></name><name><surname>Sullivan</surname><given-names>A.</given-names></name><name><surname>Biancalana</surname><given-names>V.</given-names></name><name><surname>Bröndum-Nielsen</surname><given-names>K.</given-names></name><name><surname>Hjalgrim</surname><given-names>H.</given-names></name><name><surname>Holinski-Feder</surname><given-names>E.</given-names></name><etal></etal></person-group>
<article-title>Expansion of the fragile X CGG repeat in females with premutation or intermediate alleles</article-title>
<source/>Am. J. Hum. Genet.
<year>2003</year>
<volume>72</volume>
<fpage>454</fpage>
<lpage>464</lpage>
<pub-id pub-id-type="doi">10.1086/367713</pub-id>
<pub-id pub-id-type="pmid">12529854</pub-id></element-citation>
</ref>
<ref id="B57-genes-07-00123">
<label>57.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>García-Alegría</surname><given-names>E.</given-names></name><name><surname>Ibáñez</surname><given-names>B.</given-names></name><name><surname>Mínguez</surname><given-names>M.</given-names></name><name><surname>Poch</surname><given-names>M.</given-names></name><name><surname>Valiente</surname><given-names>A.</given-names></name><name><surname>Sanz-Parra</surname><given-names>A.</given-names></name><name><surname>Martínez-Bouzas</surname><given-names>C.</given-names></name><name><surname>Beristain</surname><given-names>E.</given-names></name><name><surname>Tejada</surname><given-names>M.I.</given-names></name></person-group>
<article-title>Analysis of FMR1 gene expression in female premutation carriers using robust segmented linear regression models</article-title>
<source/>RNA
<year>2007</year>
<volume>13</volume>
<fpage>756</fpage>
<lpage>762</lpage>
<pub-id pub-id-type="doi">10.1261/rna.206307</pub-id>
<pub-id pub-id-type="pmid">17449730</pub-id></element-citation>
</ref>
<ref id="B58-genes-07-00123">
<label>58.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhou</surname><given-names>Y.</given-names></name><name><surname>Tang</surname><given-names>K.</given-names></name><name><surname>Law</surname><given-names>H.Y.</given-names></name><name><surname>Ng</surname><given-names>I.S.</given-names></name><name><surname>Lee</surname><given-names>C.G.</given-names></name><name><surname>Chong</surname><given-names>S.S.</given-names></name></person-group>
<article-title>FMR1 CGG repeat patterns and flanking haplotypes in three Asian populations and their relationship with repeat instability</article-title>
<source/>Ann. Hum. Genet.
<year>2006</year>
<volume>70</volume>
<fpage>784</fpage>
<lpage>796</lpage>
<pub-id pub-id-type="doi">10.1111/j.1469-1809.2006.00265.x</pub-id>
<pub-id pub-id-type="pmid">17044853</pub-id></element-citation>
</ref>
<ref id="B59-genes-07-00123">
<label>59.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Oostra</surname><given-names>B.A.</given-names></name><name><surname>Willemsen</surname><given-names>R.</given-names></name></person-group>
<article-title>A fragile balance: FMR1 expression levels</article-title>
<source/>Hum. Mol. Genet.
<year>2003</year>
<volume>12</volume>
<fpage>R249</fpage>
<lpage>R257</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/ddg298</pub-id>
<pub-id pub-id-type="pmid">12952862</pub-id></element-citation>
</ref>
<ref id="B60-genes-07-00123">
<label>60.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Eichler</surname><given-names>E.E.</given-names></name><name><surname>Holden</surname><given-names>J.J.</given-names></name><name><surname>Popovich</surname><given-names>B.W.</given-names></name><name><surname>Reiss</surname><given-names>A.L.</given-names></name><name><surname>Snow</surname><given-names>K.</given-names></name><name><surname>Thibodeau</surname><given-names>S.N.</given-names></name><name><surname>Richards</surname><given-names>C.S.</given-names></name><name><surname>Ward</surname><given-names>P.A.</given-names></name><name><surname>Nelson</surname><given-names>D.</given-names></name></person-group>
<article-title>Length of uninterrupted CGG repeats determines instability in the FMR1 gene</article-title>
<source/>Nat. Genet.
<year>1994</year>
<volume>8</volume>
<fpage>88</fpage>
<lpage>94</lpage>
<pub-id pub-id-type="doi">10.1038/ng0994-88</pub-id>
<pub-id pub-id-type="pmid">7987398</pub-id></element-citation>
</ref>
<ref id="B61-genes-07-00123">
<label>61.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhong</surname><given-names>N.</given-names></name><name><surname>Yang</surname><given-names>W.</given-names></name><name><surname>Dobkin</surname><given-names>C.</given-names></name><name><surname>Brown</surname><given-names>W.T.</given-names></name></person-group>
<article-title>Fragile X gene instability: Anchoring AGGs and linked microsatellites</article-title>
<source/>Am. J. Hum. Genet.
<year>1995</year>
<volume>57</volume>
<fpage>351</fpage>
<lpage>361</lpage>
<pub-id pub-id-type="pmid">7668261</pub-id></element-citation>
</ref>
<ref id="B62-genes-07-00123">
<label>62.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Murray</surname><given-names>A.</given-names></name><name><surname>Macpherson</surname><given-names>J.N.</given-names></name><name><surname>Pound</surname><given-names>M.</given-names></name><name><surname>Sharrock</surname><given-names>A.</given-names></name><name><surname>Youings</surname><given-names>S.A.</given-names></name><name><surname>Dennis</surname><given-names>N.R.</given-names></name><name><surname>McKechnie</surname><given-names>N.</given-names></name><name><surname>Linehan</surname><given-names>P.</given-names></name><name><surname>Morton</surname><given-names>N.E.</given-names></name><name><surname>Jacobs</surname><given-names>P.A.</given-names></name></person-group>
<article-title>The role of size, sequence and haplotype in the stability of FRAXA and FRAXE alleles during transmission</article-title>
<source/>Hum. Mol. Genet.
<year>1997</year>
<volume>6</volume>
<fpage>173</fpage>
<lpage>184</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/6.2.173</pub-id>
<pub-id pub-id-type="pmid">9063737</pub-id></element-citation>
</ref>
<ref id="B63-genes-07-00123">
<label>63.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kunst</surname><given-names>C.B.</given-names></name><name><surname>Warren</surname><given-names>S.T.</given-names></name></person-group>
<article-title>Cryptic and polar variation of the fragile X repeat could result in predisposing normal alleles</article-title>
<source/>Cell
<year>1994</year>
<volume>17</volume>
<fpage>853</fpage>
<lpage>861</lpage>
<pub-id pub-id-type="doi">10.1016/0092-8674(94)90134-1</pub-id>
</element-citation>
</ref>
<ref id="B64-genes-07-00123">
<label>64.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yrigollen</surname><given-names>C.M.</given-names></name><name><surname>Martorell</surname><given-names>L.</given-names></name><name><surname>Durbin-Johnson</surname><given-names>B.</given-names></name><name><surname>Naudo</surname><given-names>M.</given-names></name><name><surname>Genoves</surname><given-names>J.</given-names></name><name><surname>Murgia</surname><given-names>A.</given-names></name><name><surname>Polli</surname><given-names>R.</given-names></name><name><surname>Zhou</surname><given-names>L.</given-names></name><name><surname>Barbouth</surname><given-names>D.</given-names></name><name><surname>Rupchock</surname><given-names>A.</given-names></name><etal></etal></person-group>
<article-title>AGG interruptions and maternal age affect FMR1 CGG repeat allele stability during transmission</article-title>
<source/>J. Neurodev. Disord.
<year>2014</year>
<volume>6</volume>
<fpage>24</fpage>
<pub-id pub-id-type="doi">10.1186/1866-1955-6-24</pub-id>
<pub-id pub-id-type="pmid">25110527</pub-id></element-citation>
</ref>
<ref id="B65-genes-07-00123">
<label>65.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nolin</surname><given-names>S.L.</given-names></name><name><surname>Glicksman</surname><given-names>A.</given-names></name><name><surname>Ersalesi</surname><given-names>N.</given-names></name><name><surname>Dobkin</surname><given-names>C.</given-names></name><name><surname>Brown</surname><given-names>W.T.</given-names></name><name><surname>Cao</surname><given-names>R.</given-names></name><name><surname>Blatt</surname><given-names>E.</given-names></name><name><surname>Sah</surname><given-names>S.</given-names></name><name><surname>Latham</surname><given-names>G.J.</given-names></name><name><surname>Hadd</surname><given-names>A.G.</given-names></name></person-group>
<article-title>Fragile X full mutation expansions are inhibited by one or more AGG interruptions in premutation carriers</article-title>
<source/>Genet. Med.
<year>2014</year>
<volume>17</volume>
<fpage>358</fpage>
<lpage>364</lpage>
<pub-id pub-id-type="doi">10.1038/gim.2014.106</pub-id>
<pub-id pub-id-type="pmid">25210937</pub-id></element-citation>
</ref>
<ref id="B66-genes-07-00123">
<label>66.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Arrieta</surname><given-names>I.</given-names></name><name><surname>Peñagarikano</surname><given-names>O.</given-names></name><name><surname>Télez</surname><given-names>M.</given-names></name><name><surname>Ortega</surname><given-names>B.</given-names></name><name><surname>Flores</surname><given-names>P.</given-names></name><name><surname>Criado</surname><given-names>B.</given-names></name><name><surname>Veiga</surname><given-names>I.</given-names></name><name><surname>Peixoto</surname><given-names>A.L.</given-names></name><name><surname>Lostao</surname><given-names>C.M.</given-names></name></person-group>
<article-title>The FMR1 CGG repeat and linked microsatellite markers in two Basque valleys</article-title>
<source/>Heredity
<year>2003</year>
<volume>90</volume>
<fpage>206</fpage>
<lpage>211</lpage>
<pub-id pub-id-type="doi">10.1038/sj.hdy.6800218</pub-id>
<pub-id pub-id-type="pmid">12634803</pub-id></element-citation>
</ref>
<ref id="B67-genes-07-00123">
<label>67.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Brightwell</surname><given-names>G.</given-names></name><name><surname>Wycherley</surname><given-names>R.</given-names></name><name><surname>Waghorn</surname><given-names>A.</given-names></name></person-group>
<article-title>SNP genotyping using a simple and rapid single-tube modification of ARMS illustrated by analysis of 6 SNPs in a population of males with FRAXA repeat expansions</article-title>
<source/>Mol. Cell. Probes
<year>2002</year>
<volume>16</volume>
<fpage>297</fpage>
<lpage>305</lpage>
<pub-id pub-id-type="doi">10.1006/mcpr.2002.0424</pub-id>
<pub-id pub-id-type="pmid">12270271</pub-id></element-citation>
</ref>
<ref id="B68-genes-07-00123">
<label>68.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Barasoain</surname><given-names>M.</given-names></name><name><surname>Barrenetxea</surname><given-names>G.</given-names></name><name><surname>Ortiz-Lastra</surname><given-names>E.</given-names></name><name><surname>González</surname><given-names>J.</given-names></name><name><surname>Huerta</surname><given-names>I.</given-names></name><name><surname>Télez</surname><given-names>M.</given-names></name><name><surname>Ramírez</surname><given-names>J.M.</given-names></name><name><surname>Domínguez</surname><given-names>A.</given-names></name><name><surname>Gurtubay</surname><given-names>P.</given-names></name><name><surname>Criado</surname><given-names>B.</given-names></name><etal></etal></person-group>
<article-title>Single nucleotide polymorphism and FMR1 CGG repeat instability in two Basque valleys</article-title>
<source/>Ann. Hum. Genet.
<year>2012</year>
<volume>76</volume>
<fpage>110</fpage>
<lpage>120</lpage>
<pub-id pub-id-type="doi">10.1111/j.1469-1809.2011.00696.x</pub-id>
<pub-id pub-id-type="pmid">22211843</pub-id></element-citation>
</ref>
<ref id="B69-genes-07-00123">
<label>69.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Schneider</surname><given-names>A.</given-names></name><name><surname>Hagerman</surname><given-names>R.J.</given-names></name><name><surname>Hessl</surname><given-names>D.</given-names></name></person-group>
<article-title>Fragile X syndrome: From gene to cognition</article-title>
<source/>Dev. Disabil. Res. Rev.
<year>2009</year>
<volume>15</volume>
<fpage>333</fpage>
<lpage>342</lpage>
<pub-id pub-id-type="doi">10.1002/ddrr.80</pub-id>
<pub-id pub-id-type="pmid">20014363</pub-id></element-citation>
</ref>
<ref id="B70-genes-07-00123">
<label>70.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sidorov</surname><given-names>M.S.</given-names></name><name><surname>Auerbach</surname><given-names>B.D.</given-names></name><name><surname>Bear</surname><given-names>M.F.</given-names></name></person-group>
<article-title>Fragile X mental retardation protein and synaptic plasticity</article-title>
<source/>Mol. Brain
<year>2013</year>
<volume>6</volume>
<fpage>15</fpage>
<pub-id pub-id-type="doi">10.1186/1756-6606-6-15</pub-id>
<pub-id pub-id-type="pmid">23566911</pub-id></element-citation>
</ref>
<ref id="B71-genes-07-00123">
<label>71.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Peñagarikano</surname><given-names>O.</given-names></name><name><surname>Muller</surname><given-names>J.G.</given-names></name><name><surname>Warren</surname><given-names>S.T.</given-names></name></person-group>
<article-title>The pathophysiology of Fragile X Syndrome</article-title>
<source/>Annu. Rev. Genom. Hum. Genet.
<year>2007</year>
<volume>8</volume>
<fpage>109</fpage>
<lpage>129</lpage>
<pub-id pub-id-type="doi">10.1146/annurev.genom.8.080706.092249</pub-id>
<pub-id pub-id-type="pmid">17477822</pub-id></element-citation>
</ref>
<ref id="B72-genes-07-00123">
<label>72.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ashley</surname><given-names>C.T.</given-names><suffix>Jr.</suffix></name><name><surname>Wilkinson</surname><given-names>K.D.</given-names></name><name><surname>Reines</surname><given-names>D.</given-names></name><name><surname>Warren</surname><given-names>S.T.</given-names></name></person-group>
<article-title>FMR1 protein: Conserved RNP family domains and selective RNA binding</article-title>
<source/>Science
<year>1993</year>
<volume>262</volume>
<fpage>563</fpage>
<lpage>566</lpage>
<pub-id pub-id-type="doi">10.1126/science.7692601</pub-id>
<pub-id pub-id-type="pmid">7692601</pub-id></element-citation>
</ref>
<ref id="B73-genes-07-00123">
<label>73.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Adinolfi</surname><given-names>S.</given-names></name><name><surname>Ramos</surname><given-names>A.</given-names></name><name><surname>Martin</surname><given-names>S.R.</given-names></name><name><surname>Dal Piaz</surname><given-names>F.</given-names></name><name><surname>Pucci</surname><given-names>P.</given-names></name><name><surname>Bardoni</surname><given-names>B.</given-names></name><name><surname>Mandel</surname><given-names>J.L.</given-names></name><name><surname>Pastore</surname><given-names>A.</given-names></name></person-group>
<article-title>The <italic>N</italic>-terminus of the Fragile X mental retardation protein contains a novel domain involved in dimerization and RNA binding</article-title>
<source/>Biochemistry
<year>2003</year>
<volume>42</volume>
<fpage>10437</fpage>
<lpage>10444</lpage>
<pub-id pub-id-type="doi">10.1021/bi034909g</pub-id>
<pub-id pub-id-type="pmid">12950170</pub-id></element-citation>
</ref>
<ref id="B74-genes-07-00123">
<label>74.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Garber</surname><given-names>K.</given-names></name><name><surname>Smith</surname><given-names>K.T.</given-names></name><name><surname>Reines</surname><given-names>D.</given-names></name><name><surname>Warren</surname><given-names>S.T.</given-names></name></person-group>
<article-title>Transcription, translation and fragile X syndrome</article-title>
<source/>Curr. Opin. Genet. Dev.
<year>2006</year>
<volume>16</volume>
<fpage>270</fpage>
<lpage>275</lpage>
<pub-id pub-id-type="doi">10.1016/j.gde.2006.04.010</pub-id>
<pub-id pub-id-type="pmid">16647847</pub-id></element-citation>
</ref>
<ref id="B75-genes-07-00123">
<label>75.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Brown</surname><given-names>V.</given-names></name><name><surname>Jin</surname><given-names>P.</given-names></name><name><surname>Ceman</surname><given-names>S.</given-names></name><name><surname>Darnell</surname><given-names>J.C.</given-names></name><name><surname>O’Donell</surname><given-names>W.T.</given-names></name><name><surname>Tenenbaum</surname><given-names>S.A.</given-names></name><name><surname>Jin</surname><given-names>X.K.</given-names></name><name><surname>Feng</surname><given-names>Y.</given-names></name><name><surname>Wilkinson</surname><given-names>K.D.</given-names></name><name><surname>Keene</surname><given-names>J.D.</given-names></name><etal></etal></person-group>
<article-title>Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in Fragile X syndrome</article-title>
<source/>Cell
<year>2001</year>
<volume>107</volume>
<fpage>477</fpage>
<lpage>487</lpage>
<pub-id pub-id-type="doi">10.1016/S0092-8674(01)00568-2</pub-id>
<pub-id pub-id-type="pmid">11719188</pub-id></element-citation>
</ref>
<ref id="B76-genes-07-00123">
<label>76.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Darnell</surname><given-names>J.C.</given-names></name><name><surname>Jensen</surname><given-names>K.B.</given-names></name><name><surname>Jin</surname><given-names>P.</given-names></name><name><surname>Brown</surname><given-names>V.</given-names></name><name><surname>Warren</surname><given-names>S.T.</given-names></name><name><surname>Darnell</surname><given-names>R.B.</given-names></name></person-group>
<article-title>Fragile X mental retardation protein targets G quartet mRNAs important for neuronal function</article-title>
<source/>Cell
<year>2001</year>
<volume>107</volume>
<fpage>489</fpage>
<lpage>499</lpage>
<pub-id pub-id-type="doi">10.1016/S0092-8674(01)00566-9</pub-id>
<pub-id pub-id-type="pmid">11719189</pub-id></element-citation>
</ref>
<ref id="B77-genes-07-00123">
<label>77.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Huber</surname><given-names>K.M.</given-names></name></person-group>
<article-title>The fragile X-cerebellum connection</article-title>
<source/>Trends Neurosci.
<year>2006</year>
<volume>29</volume>
<fpage>183</fpage>
<lpage>185</lpage>
<pub-id pub-id-type="doi">10.1016/j.tins.2006.02.001</pub-id>
<pub-id pub-id-type="pmid">16500716</pub-id></element-citation>
</ref>
<ref id="B78-genes-07-00123">
<label>78.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bear</surname><given-names>M.F.</given-names></name><name><surname>Huber</surname><given-names>K.M.</given-names></name><name><surname>Warren</surname><given-names>S.T.</given-names></name></person-group>
<article-title>The mGluR theory of Fragile X mental retardation</article-title>
<source/>Trends Neurosci.
<year>2004</year>
<volume>27</volume>
<fpage>370</fpage>
<lpage>377</lpage>
<pub-id pub-id-type="doi">10.1016/j.tins.2004.04.009</pub-id>
<pub-id pub-id-type="pmid">15219735</pub-id></element-citation>
</ref>
<ref id="B79-genes-07-00123">
<label>79.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yan</surname><given-names>Q.J.</given-names></name><name><surname>Rammal</surname><given-names>M.</given-names></name><name><surname>Tranfaglia</surname><given-names>M.</given-names></name><name><surname>Bauchwitz</surname><given-names>R.P.</given-names></name></person-group>
<article-title>Suppression of two major Fragile X syndrome mouse model phenotypes by the mGluR5 antagonist MPEP</article-title>
<source/>Neuropharmacology
<year>2005</year>
<volume>49</volume>
<fpage>1053</fpage>
<lpage>1066</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuropharm.2005.06.004</pub-id>
<pub-id pub-id-type="pmid">16054174</pub-id></element-citation>
</ref>
<ref id="B80-genes-07-00123">
<label>80.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tassone</surname><given-names>F.</given-names></name><name><surname>Hagerman</surname><given-names>R.J.</given-names></name><name><surname>Taylor</surname><given-names>A.K.</given-names></name><name><surname>Gane</surname><given-names>L.W.</given-names></name><name><surname>Godfrey</surname><given-names>T.E.</given-names></name><name><surname>Hagerman</surname><given-names>P.J.</given-names></name></person-group>
<article-title>Elevated levels of FMR1 mRNA in carrier males: A new mechanism of involvement in the fragile-X syndrome</article-title>
<source/>Am. J. Hum. Genet.
<year>2000</year>
<volume>66</volume>
<fpage>6</fpage>
<lpage>15</lpage>
<pub-id pub-id-type="doi">10.1086/302720</pub-id>
<pub-id pub-id-type="pmid">10631132</pub-id></element-citation>
</ref>
<ref id="B81-genes-07-00123">
<label>81.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tassone</surname><given-names>F.</given-names></name><name><surname>Hagerman</surname><given-names>R.J.</given-names></name><name><surname>Chamberlain</surname><given-names>W.D.</given-names></name><name><surname>Hagerman</surname><given-names>P.J.</given-names></name></person-group>
<article-title>Transcription of the FMR1 gene in individuals with fragile X syndrome</article-title>
<source/>Am. J. Med. Genet.
<year>2000</year>
<volume>97</volume>
<fpage>195</fpage>
<lpage>203</lpage>
<pub-id pub-id-type="doi">10.1002/1096-8628(200023)97:3&lt;195::AID-AJMG1037&gt;3.0.CO;2-R</pub-id>
<pub-id pub-id-type="pmid">11449488</pub-id></element-citation>
</ref>
<ref id="B82-genes-07-00123">
<label>82.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tassone</surname><given-names>F.</given-names></name><name><surname>Hagerman</surname><given-names>P.J.</given-names></name></person-group>
<article-title>Expression of the FMR1 gene</article-title>
<source/>Cytogenet. Genome Res.
<year>2003</year>
<volume>100</volume>
<fpage>124</fpage>
<lpage>128</lpage>
<pub-id pub-id-type="doi">10.1159/000072846</pub-id>
<pub-id pub-id-type="pmid">14526172</pub-id></element-citation>
</ref>
<ref id="B83-genes-07-00123">
<label>83.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tassone</surname><given-names>F.</given-names></name><name><surname>De Rubeis</surname><given-names>S.</given-names></name><name><surname>Carosi</surname><given-names>C.</given-names></name><name><surname>La Fata</surname><given-names>G.</given-names></name><name><surname>Serpa</surname><given-names>G.</given-names></name><name><surname>Raske</surname><given-names>C.</given-names></name><name><surname>Willemsen</surname><given-names>R.</given-names></name><name><surname>Hagerman</surname><given-names>P.J.</given-names></name><name><surname>Bagni</surname><given-names>C.</given-names></name></person-group>
<article-title>Differential usage of transcriptional start sites and polyadenylation sites in FMR1 premutation alleles</article-title>
<source/>Nucleic Acids Res.
<year>2011</year>
<volume>39</volume>
<fpage>6172</fpage>
<lpage>6185</lpage>
<pub-id pub-id-type="doi">10.1093/nar/gkr100</pub-id>
<pub-id pub-id-type="pmid">21478165</pub-id></element-citation>
</ref>
<ref id="B84-genes-07-00123">
<label>84.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Martin</surname><given-names>J.</given-names></name><name><surname>Bell</surname><given-names>J.</given-names></name></person-group>
<article-title>A pedigree of mental defect showing sex linkage</article-title>
<source/>Arch. Neurol. Psychiatry
<year>1943</year>
<volume>6</volume>
<fpage>154</fpage>
<lpage>157</lpage>
<pub-id pub-id-type="doi">10.1136/jnnp.6.3-4.154</pub-id>
</element-citation>
</ref>
<ref id="B85-genes-07-00123">
<label>85.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lehrke</surname><given-names>R.G.</given-names></name></person-group>
<article-title>X-linked mental retardation and verbal disability</article-title>
<source/>Birth Defects Orig. Artic. Ser.
<year>1974</year>
<volume>10</volume>
<fpage>1</fpage>
<lpage>100</lpage>
<pub-id pub-id-type="pmid">4458821</pub-id></element-citation>
</ref>
<ref id="B86-genes-07-00123">
<label>86.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lubs</surname><given-names>H.A.</given-names></name></person-group>
<article-title>A marker X chromosome</article-title>
<source/>Am. J. Hum. Genet.
<year>1969</year>
<volume>21</volume>
<fpage>231</fpage>
<lpage>244</lpage>
<pub-id pub-id-type="pmid">5794013</pub-id></element-citation>
</ref>
<ref id="B87-genes-07-00123">
<label>87.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Harrison</surname><given-names>C.J.</given-names></name><name><surname>Jack</surname><given-names>E.M.</given-names></name><name><surname>Allen</surname><given-names>T.D.</given-names></name><name><surname>Harris</surname><given-names>R.</given-names></name></person-group>
<article-title>The fragile X: A scanning electron microscope study</article-title>
<source/>J. Med. Genet.
<year>1983</year>
<volume>20</volume>
<fpage>280</fpage>
<lpage>285</lpage>
<pub-id pub-id-type="doi">10.1136/jmg.20.4.280</pub-id>
<pub-id pub-id-type="pmid">6684694</pub-id></element-citation>
</ref>
<ref id="B88-genes-07-00123">
<label>88.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Richards</surname><given-names>B.W.</given-names></name><name><surname>Sylvester</surname><given-names>P.E.</given-names></name><name><surname>Brooker</surname><given-names>C.</given-names></name></person-group>
<article-title>Fragile X linked mental retardation: The Martin Bell syndrome</article-title>
<source/>J. Ment. Defic. Res.
<year>1981</year>
<volume>25</volume>
<fpage>253</fpage>
<lpage>256</lpage>
<pub-id pub-id-type="doi">10.1111/j.1365-2788.1981.tb00115.x</pub-id>
<pub-id pub-id-type="pmid">7328634</pub-id></element-citation>
</ref>
<ref id="B89-genes-07-00123">
<label>89.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sherman</surname><given-names>S.L.</given-names></name><name><surname>Morton</surname><given-names>N.E.</given-names></name><name><surname>Jacobs</surname><given-names>P.A.</given-names></name><name><surname>Turner</surname><given-names>G.</given-names></name></person-group>
<article-title>The marker (X) syndrome: A cytogenetic and genetic analysis</article-title>
<source/>Ann. Hum. Genet.
<year>1984</year>
<volume>48</volume>
<fpage>21</fpage>
<lpage>37</lpage>
<pub-id pub-id-type="doi">10.1111/j.1469-1809.1984.tb00830.x</pub-id>
<pub-id pub-id-type="pmid">6712153</pub-id></element-citation>
</ref>
<ref id="B90-genes-07-00123">
<label>90.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Richards</surname><given-names>R.I.</given-names></name><name><surname>Sutherland</surname><given-names>G.R.</given-names></name></person-group>
<article-title>Simple repeat DNA is not replicated simply</article-title>
<source/>Nat. Genet.
<year>1994</year>
<volume>6</volume>
<fpage>114</fpage>
<lpage>116</lpage>
<pub-id pub-id-type="doi">10.1038/ng0294-114</pub-id>
<pub-id pub-id-type="pmid">8162063</pub-id></element-citation>
</ref>
<ref id="B91-genes-07-00123">
<label>91.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tabolacci</surname><given-names>E.</given-names></name><name><surname>Moscato</surname><given-names>U.</given-names></name><name><surname>Zalfa</surname><given-names>F.</given-names></name><name><surname>Bagni</surname><given-names>C.</given-names></name><name><surname>Chiurazzi</surname><given-names>P.</given-names></name><name><surname>Neri</surname><given-names>G.</given-names></name></person-group>
<article-title>Epigenetic analysis reveals a euchromatic configuration in the FMR1 unmethylated full mutations</article-title>
<source/>Eur. J. Hum. Genet.
<year>2008</year>
<volume>16</volume>
<fpage>1487</fpage>
<lpage>1498</lpage>
<pub-id pub-id-type="doi">10.1038/ejhg.2008.130</pub-id>
<pub-id pub-id-type="pmid">18628788</pub-id></element-citation>
</ref>
<ref id="B92-genes-07-00123">
<label>92.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nolin</surname><given-names>S.L.</given-names></name><name><surname>Lewis</surname><given-names>F.A.</given-names><suffix>III</suffix></name><name><surname>Ye</surname><given-names>L.L.</given-names></name><name><surname>Houck</surname><given-names>G.E.</given-names><suffix>Jr.</suffix></name><name><surname>Glicksman</surname><given-names>A.E.</given-names></name><name><surname>Limprasert</surname><given-names>P.</given-names></name><name><surname>Li</surname><given-names>S.Y.</given-names></name><name><surname>Zhong</surname><given-names>N.</given-names></name><name><surname>Ashley</surname><given-names>A.E.</given-names></name><name><surname>Feingold</surname><given-names>E.</given-names></name><etal></etal></person-group>
<article-title>Familial transmission of the FMR1 CGG repeat</article-title>
<source/>Am. J. Hum. Genet.
<year>1996</year>
<volume>59</volume>
<fpage>1252</fpage>
<lpage>1261</lpage>
<pub-id pub-id-type="pmid">8940270</pub-id></element-citation>
</ref>
<ref id="B93-genes-07-00123">
<label>93.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gedeon</surname><given-names>A.K.</given-names></name><name><surname>Baker</surname><given-names>E.</given-names></name><name><surname>Robinson</surname><given-names>H.</given-names></name><name><surname>Partington</surname><given-names>M.W.</given-names></name><name><surname>Gross</surname><given-names>B.</given-names></name><name><surname>Manca</surname><given-names>A.</given-names></name><name><surname>Korn</surname><given-names>B.</given-names></name><name><surname>Poustka</surname><given-names>A.</given-names></name><name><surname>Yu</surname><given-names>S.</given-names></name><name><surname>Sutherland</surname><given-names>G.R.</given-names></name><etal></etal></person-group>
<article-title>Fragile X syndrome without CCG amplification has an FMR1 deletion</article-title>
<source/>Nat. Genet.
<year>1992</year>
<volume>1</volume>
<fpage>341</fpage>
<lpage>344</lpage>
<pub-id pub-id-type="doi">10.1038/ng0892-341</pub-id>
<pub-id pub-id-type="pmid">1302032</pub-id></element-citation>
</ref>
<ref id="B94-genes-07-00123">
<label>94.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>De Boulle</surname><given-names>K.</given-names></name><name><surname>Verkerk</surname><given-names>A.J.M.H.</given-names></name><name><surname>Rreyniers</surname><given-names>E.</given-names></name><name><surname>Vits</surname><given-names>L.</given-names></name><name><surname>Hendrickx</surname><given-names>J.</given-names></name><name><surname>Van Roy</surname><given-names>B.</given-names></name><name><surname>Van Den Bos</surname><given-names>F.</given-names></name><name><surname>De Graaf</surname><given-names>E.</given-names></name><name><surname>Oostra</surname><given-names>B.A.</given-names></name><name><surname>Willems</surname><given-names>P.J.</given-names></name></person-group>
<article-title>A point mutation in the FMR-1 gene associated with the Fragile X mental retardation</article-title>
<source/>Nat. Genet.
<year>1993</year>
<volume>3</volume>
<fpage>31</fpage>
<lpage>35</lpage>
<pub-id pub-id-type="doi">10.1038/ng0193-31</pub-id>
<pub-id pub-id-type="pmid">8490650</pub-id></element-citation>
</ref>
<ref id="B95-genes-07-00123">
<label>95.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Handt</surname><given-names>M.</given-names></name><name><surname>Epplen</surname><given-names>A.</given-names></name><name><surname>Hoffjan</surname><given-names>S.</given-names></name><name><surname>Mese</surname><given-names>K.</given-names></name><name><surname>Epplen</surname><given-names>J.T.</given-names></name><name><surname>Dekomien</surname><given-names>G.</given-names></name></person-group>
<article-title>Point mutation frequency in the FMR1 gene as revealed by fragile X syndrome screening</article-title>
<source/>Mol. Cell. Probes
<year>2014</year>
<volume>28</volume>
<fpage>279</fpage>
<lpage>283</lpage>
<pub-id pub-id-type="doi">10.1016/j.mcp.2014.08.003</pub-id>
<pub-id pub-id-type="pmid">25171808</pub-id></element-citation>
</ref>
<ref id="B96-genes-07-00123">
<label>96.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Myrick</surname><given-names>L.K.</given-names></name><name><surname>Nakamoto-Kinoshita</surname><given-names>M.</given-names></name><name><surname>Lindor</surname><given-names>N.M.</given-names></name><name><surname>Kirmani</surname><given-names>S.</given-names></name><name><surname>Cheng</surname><given-names>X.</given-names></name><name><surname>Warren</surname><given-names>S.T.</given-names></name></person-group>
<article-title>Fragile X syndrome due to a missense mutation</article-title>
<source/>Eur. J. Hum. Genet.
<year>2014</year>
<volume>22</volume>
<fpage>1185</fpage>
<lpage>1189</lpage>
<pub-id pub-id-type="doi">10.1038/ejhg.2013.311</pub-id>
<pub-id pub-id-type="pmid">24448548</pub-id></element-citation>
</ref>
<ref id="B97-genes-07-00123">
<label>97.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fernández-Carvajal</surname><given-names>I.</given-names></name><name><surname>Walichiewicz</surname><given-names>P.</given-names></name><name><surname>Xiaosen</surname><given-names>X.</given-names></name><name><surname>Pan</surname><given-names>R.</given-names></name><name><surname>Hagerman</surname><given-names>P.J.</given-names></name><name><surname>Tassone</surname><given-names>F.</given-names></name></person-group>
<article-title>Screening for expanded alleles of the FMR1 gene in blood spots from newborn males in a Spanish population</article-title>
<source/>J. Mol. Diagn.
<year>2009</year>
<volume>11</volume>
<fpage>324</fpage>
<lpage>329</lpage>
<pub-id pub-id-type="doi">10.2353/jmoldx.2009.080173</pub-id>
<pub-id pub-id-type="pmid">19460941</pub-id></element-citation>
</ref>
<ref id="B98-genes-07-00123">
<label>98.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hagerman</surname><given-names>R.J.</given-names></name><name><surname>Berry-Kravis</surname><given-names>E.</given-names></name><name><surname>Kaufmann</surname><given-names>W.E.</given-names></name><name><surname>Ono</surname><given-names>M.Y.</given-names></name><name><surname>Tartaglia</surname><given-names>N.</given-names></name><name><surname>Lachiewicz</surname><given-names>A.</given-names></name><name><surname>Kronk</surname><given-names>R.</given-names></name><name><surname>Delahunty</surname><given-names>C.</given-names></name><name><surname>Hessl</surname><given-names>D.</given-names></name><name><surname>Visootsak</surname><given-names>J.</given-names></name><etal></etal></person-group>
<article-title>Advances in the treatment of fragile X syndrome</article-title>
<source/>Pediatrics
<year>2009</year>
<volume>123</volume>
<fpage>378</fpage>
<lpage>390</lpage>
<pub-id pub-id-type="doi">10.1542/peds.2008-0317</pub-id>
<pub-id pub-id-type="pmid">19117905</pub-id></element-citation>
</ref>
<ref id="B99-genes-07-00123">
<label>99.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Besterman</surname><given-names>A.D.</given-names></name><name><surname>Wilke</surname><given-names>S.A.</given-names></name><name><surname>Mulligan</surname><given-names>T.E.</given-names></name><name><surname>Allison</surname><given-names>S.C.</given-names></name><name><surname>Hagerman</surname><given-names>R.</given-names></name><name><surname>Seritan</surname><given-names>A.L.</given-names></name><name><surname>Bourgeois</surname><given-names>A.</given-names></name></person-group>
<article-title>Towards an understanding of neuropsychiatric manifestations in fragile X premutation carriers</article-title>
<source/>Future Neurol.
<year>2014</year>
<volume>9</volume>
<fpage>227</fpage>
<lpage>239</lpage>
<pub-id pub-id-type="doi">10.2217/fnl.14.11</pub-id>
<pub-id pub-id-type="pmid">25013385</pub-id></element-citation>
</ref>
<ref id="B100-genes-07-00123">
<label>100.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hagerman</surname><given-names>R.J.</given-names></name><name><surname>Leehey</surname><given-names>M.</given-names></name><name><surname>Heinrichs</surname><given-names>W.</given-names></name><name><surname>Tassone</surname><given-names>F.</given-names></name><name><surname>Wilson</surname><given-names>R.</given-names></name><name><surname>Hills</surname><given-names>J.</given-names></name><name><surname>Grigsby</surname><given-names>J.</given-names></name><name><surname>Gage</surname><given-names>B.</given-names></name><name><surname>Hagerman</surname><given-names>P.J.</given-names></name></person-group>
<article-title>Intention tremor, parkinsonism and generalized brain atrophy in male carriers of fragile X</article-title>
<source/>Neurology
<year>2001</year>
<volume>57</volume>
<fpage>127</fpage>
<lpage>130</lpage>
<pub-id pub-id-type="doi">10.1212/WNL.57.1.127</pub-id>
<pub-id pub-id-type="pmid">11445641</pub-id></element-citation>
</ref>
<ref id="B101-genes-07-00123">
<label>101.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Greco</surname><given-names>C.M.</given-names></name><name><surname>Hagerman</surname><given-names>R.J.</given-names></name><name><surname>Tassone</surname><given-names>F.</given-names></name><name><surname>Chudley</surname><given-names>A.E.</given-names></name><name><surname>Del Bigio</surname><given-names>M.R.</given-names></name><name><surname>Jacquemont</surname><given-names>S.</given-names></name><name><surname>Leehey</surname><given-names>P.</given-names></name><name><surname>Hagerman</surname><given-names>P.J.</given-names></name></person-group>
<article-title>Neuronal intranuclear inclusions in a new cerebellar tremor/ataxia syndrome among fragile X carriers</article-title>
<source/>Brain
<year>2002</year>
<volume>125</volume>
<issue>Pt 8</issue>
<fpage>1760</fpage>
<lpage>1771</lpage>
<pub-id pub-id-type="doi">10.1093/brain/awf184</pub-id>
<pub-id pub-id-type="pmid">12135967</pub-id></element-citation>
</ref>
<ref id="B102-genes-07-00123">
<label>102.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Greco</surname><given-names>C.M.</given-names></name><name><surname>Berman</surname><given-names>R.F.</given-names></name><name><surname>Martin</surname><given-names>R.M.</given-names></name><name><surname>Tassone</surname><given-names>F.</given-names></name><name><surname>Schwartz</surname><given-names>P.H.</given-names></name><name><surname>Chang</surname><given-names>A.</given-names></name><name><surname>Trapp</surname><given-names>B.D.</given-names></name><name><surname>Iwahashi</surname><given-names>C.</given-names></name><name><surname>Brunberg</surname><given-names>J.</given-names></name><name><surname>Grigsby</surname><given-names>J.</given-names></name><etal></etal></person-group>
<article-title>Neuropathology of fragile X-associated tremor/ataxia syndrome (FXTAS)</article-title>
<source/>Brain
<year>2006</year>
<volume>129</volume>
<fpage>243</fpage>
<lpage>255</lpage>
<pub-id pub-id-type="doi">10.1093/brain/awh683</pub-id>
<pub-id pub-id-type="pmid">16332642</pub-id></element-citation>
</ref>
<ref id="B103-genes-07-00123">
<label>103.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Willemsen</surname><given-names>R.</given-names></name><name><surname>Hoogeveen-Westerveld</surname><given-names>M.</given-names></name><name><surname>Reis</surname><given-names>S.</given-names></name><name><surname>Holstege</surname><given-names>J.</given-names></name><name><surname>Severijnen</surname><given-names>L.A.</given-names></name><name><surname>Nieuwenhuizen</surname><given-names>I.M.</given-names></name><name><surname>Schrier</surname><given-names>M.</given-names></name><name><surname>van Unen</surname><given-names>L.</given-names></name><name><surname>Tassone</surname><given-names>F.</given-names></name><name><surname>Hoogeveen</surname><given-names>A.T.</given-names></name><etal></etal></person-group>
<article-title>The FMR1 CGG repeat mouse displays ubiquitin-positive intranuclear neuronal inclusions; implications for the cerebellar tremor/ataxia syndrome</article-title>
<source/>Hum. Mol. Genet.
<year>2003</year>
<volume>12</volume>
<fpage>949</fpage>
<lpage>959</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/ddg114</pub-id>
<pub-id pub-id-type="pmid">12700164</pub-id></element-citation>
</ref>
<ref id="B104-genes-07-00123">
<label>104.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tassone</surname><given-names>F.</given-names></name><name><surname>Adams</surname><given-names>J.</given-names></name><name><surname>Berry-Kravis</surname><given-names>E.M.</given-names></name><name><surname>Cohen</surname><given-names>S.S.</given-names></name><name><surname>Brusco</surname><given-names>A.</given-names></name><name><surname>Leehey</surname><given-names>M.A.</given-names></name><name><surname>Li</surname><given-names>L.</given-names></name><name><surname>Hagerman</surname><given-names>R.J.</given-names></name><name><surname>Hagerman</surname><given-names>P.J.</given-names></name></person-group>
<article-title>CGG repeat length correlates with age of onset of motor signs of the fragile C-associated tremor/ataxia syndrome (FXTAS)</article-title>
<source/>Am. J. Med. Genet. B Neuropsychiatr. Genet.
<year>2007</year>
<volume>144</volume>
<fpage>566</fpage>
<lpage>569</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.b.30482</pub-id>
<pub-id pub-id-type="pmid">17427188</pub-id></element-citation>
</ref>
<ref id="B105-genes-07-00123">
<label>105.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hagerman</surname><given-names>R.J.</given-names></name><name><surname>Hagerman</surname><given-names>P.J.</given-names></name></person-group>
<article-title>The fragile x premutation: Into the phenotypic fold</article-title>
<source/>Curr. Opin. Genet. Dev.
<year>2002</year>
<volume>12</volume>
<fpage>278</fpage>
<lpage>283</lpage>
<pub-id pub-id-type="doi">10.1016/S0959-437X(02)00299-X</pub-id>
<pub-id pub-id-type="pmid">12076670</pub-id></element-citation>
</ref>
<ref id="B106-genes-07-00123">
<label>106.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hall</surname><given-names>D.</given-names></name><name><surname>Tassone</surname><given-names>F.</given-names></name><name><surname>Klepitskaya</surname><given-names>O.</given-names></name><name><surname>Leehey</surname><given-names>M.</given-names></name></person-group>
<article-title>Fragile X-associated tremor ataxia syndrome in FMR1 gray zone allele carriers</article-title>
<source/>Mov. Disord.
<year>2012</year>
<volume>27</volume>
<fpage>296</fpage>
<lpage>300</lpage>
<pub-id pub-id-type="doi">10.1002/mds.24021</pub-id>
<pub-id pub-id-type="pmid">22161987</pub-id></element-citation>
</ref>
<ref id="B107-genes-07-00123">
<label>107.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Winarni</surname><given-names>T.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Tassone</surname><given-names>F.</given-names></name><name><surname>Hagerman</surname><given-names>R.</given-names></name></person-group>
<article-title>Fragile X-associated tremor/ataxia syndrome (FXTAS) in grey zone carriers</article-title>
<source/>Clin. Genet.
<year>2013</year>
<volume>84</volume>
<fpage>74</fpage>
<lpage>77</lpage>
<pub-id pub-id-type="doi">10.1111/cge.12026</pub-id>
<pub-id pub-id-type="pmid">23009394</pub-id></element-citation>
</ref>
<ref id="B108-genes-07-00123">
<label>108.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hagerman</surname><given-names>R.J.</given-names></name><name><surname>Hagerman</surname><given-names>P.J.</given-names></name></person-group>
<article-title>Fragile-X-associated tremor/ataxia syndrome (FXTAS) in females with the FMR1 premutation</article-title>
<source/>Am. J. Hum. Genet.
<year>2004</year>
<volume>74</volume>
<fpage>1051</fpage>
<lpage>1056</lpage>
<pub-id pub-id-type="doi">10.1086/420700</pub-id>
<pub-id pub-id-type="pmid">15065016</pub-id></element-citation>
</ref>
<ref id="B109-genes-07-00123">
<label>109.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cronister</surname><given-names>A.</given-names></name><name><surname>Schreiner</surname><given-names>R.</given-names></name><name><surname>Wittenberger</surname><given-names>M.</given-names></name><name><surname>Amiri</surname><given-names>K.</given-names></name><name><surname>Harris</surname><given-names>K.</given-names></name><name><surname>Hagerman</surname><given-names>R.J.</given-names></name></person-group>
<article-title>Heterozygous fragile X female: Historical, physical, cognitive and cytogenetic features</article-title>
<source/>Am. J. Med. Genet.
<year>1991</year>
<volume>38</volume>
<fpage>269</fpage>
<lpage>274</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.1320380221</pub-id>
<pub-id pub-id-type="pmid">2018071</pub-id></element-citation>
</ref>
<ref id="B110-genes-07-00123">
<label>110.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Schwartz</surname><given-names>C.E.</given-names></name><name><surname>Dean</surname><given-names>J.</given-names></name><name><surname>Howard-Peebles</surname><given-names>P.N.</given-names></name><name><surname>Bugge</surname><given-names>M.</given-names></name><name><surname>Mikkelsen</surname><given-names>M.</given-names></name><name><surname>Tommerup</surname><given-names>N.</given-names></name><name><surname>Hull</surname><given-names>C.</given-names></name><name><surname>Hagerman</surname><given-names>R.</given-names></name><name><surname>Holden</surname><given-names>J.J.</given-names></name><name><surname>Stevenson</surname><given-names>R.E.</given-names></name></person-group>
<article-title>Obstetrical and gynecological complications in fragile X carriers: A multicenter study</article-title>
<source/>Am. J. Med. Genet.
<year>1994</year>
<volume>51</volume>
<fpage>400</fpage>
<lpage>402</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.1320510419</pub-id>
<pub-id pub-id-type="pmid">7943006</pub-id></element-citation>
</ref>
<ref id="B111-genes-07-00123">
<label>111.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Allingham-Hawkins</surname><given-names>D.J.</given-names></name><name><surname>Babul-Hirji</surname><given-names>R.</given-names></name><name><surname>Chitayat</surname><given-names>D.</given-names></name><name><surname>Holden</surname><given-names>J.J.</given-names></name><name><surname>Yang</surname><given-names>K.T.</given-names></name><name><surname>Lee</surname><given-names>C.</given-names></name><name><surname>Hudson</surname><given-names>R.</given-names></name><name><surname>Gorwill</surname><given-names>H.</given-names></name><name><surname>Nolin</surname><given-names>S.L.</given-names></name><name><surname>Glicksman</surname><given-names>A.</given-names></name><etal></etal></person-group>
<article-title>Fragile X premutation is a significant risk factor for premature ovarian failure: The International Collaborative POF in Fragile X study—Preliminary data</article-title>
<source/>Am. J. Med. Genet.
<year>1999</year>
<volume>83</volume>
<fpage>322</fpage>
<lpage>325</lpage>
<pub-id pub-id-type="doi">10.1002/(SICI)1096-8628(19990402)83:4&lt;322::AID-AJMG17&gt;3.0.CO;2-B</pub-id>
<pub-id pub-id-type="pmid">10208170</pub-id></element-citation>
</ref>
<ref id="B112-genes-07-00123">
<label>112.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vianna-Morgante</surname><given-names>A.M.</given-names></name><name><surname>Costa</surname><given-names>S.S.</given-names></name><name><surname>Pavanello</surname><given-names>R.C.</given-names></name><name><surname>Otto</surname><given-names>P.A.M.</given-names></name></person-group>
<article-title>Mingroni-Netto, R.C. Premature ovarian failure (POF) in Brazilian fragile X carriers</article-title>
<source/>Genet. Mol. Biol.
<year>1999</year>
<volume>22</volume>
<fpage>471</fpage>
<lpage>474</lpage>
<pub-id pub-id-type="doi">10.1590/S1415-47571999000400002</pub-id>
</element-citation>
</ref>
<ref id="B113-genes-07-00123">
<label>113.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Murray</surname><given-names>A.</given-names></name><name><surname>Ennis</surname><given-names>S.</given-names></name><name><surname>MacSwiney</surname><given-names>F.</given-names></name><name><surname>Webb</surname><given-names>J.</given-names></name><name><surname>Morton</surname><given-names>N.E.</given-names></name></person-group>
<article-title>Reproductive and menstrual history of females with fragile X expansions</article-title>
<source/>Eur. J. Hum. Genet.
<year>2000</year>
<volume>8</volume>
<fpage>247</fpage>
<lpage>252</lpage>
<pub-id pub-id-type="doi">10.1038/sj.ejhg.5200451</pub-id>
<pub-id pub-id-type="pmid">10854106</pub-id></element-citation>
</ref>
<ref id="B114-genes-07-00123">
<label>114.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mallolas</surname><given-names>J.</given-names></name><name><surname>Duran</surname><given-names>M.</given-names></name><name><surname>Sánchez</surname><given-names>A.</given-names></name><name><surname>Jimenez</surname><given-names>D.</given-names></name><name><surname>Castellvi-Bel</surname><given-names>S.</given-names></name><name><surname>Rife</surname><given-names>M.</given-names></name><name><surname>Milá</surname><given-names>M.</given-names></name></person-group>
<article-title>Implications of the FMR1 gene in menopause: Study of 147 Spanish women</article-title>
<source/>Menopause
<year>2001</year>
<volume>8</volume>
<fpage>106</fpage>
<lpage>110</lpage>
<pub-id pub-id-type="doi">10.1097/00042192-200103000-00005</pub-id>
<pub-id pub-id-type="pmid">11256870</pub-id></element-citation>
</ref>
<ref id="B115-genes-07-00123">
<label>115.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hundscheid</surname><given-names>R.D.</given-names></name><name><surname>Smits</surname><given-names>A.O.</given-names></name><name><surname>Thomas</surname><given-names>C.M.</given-names></name><name><surname>Kiemeney</surname><given-names>L.A.</given-names></name><name><surname>Braat</surname><given-names>D.D.</given-names></name></person-group>
<article-title>Female carriers of fragile X premutations have no increased risk for additional diseases other than premature ovarian failure</article-title>
<source/>Am. J. Med. Genet.
<year>2003</year>
<volume>117A</volume>
<fpage>6</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.a.10862</pub-id>
<pub-id pub-id-type="pmid">12548733</pub-id></element-citation>
</ref>
<ref id="B116-genes-07-00123">
<label>116.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sullivan</surname><given-names>A.K.</given-names></name><name><surname>Marcus</surname><given-names>M.</given-names></name><name><surname>Epstein</surname><given-names>M.P.</given-names></name><name><surname>Allen</surname><given-names>E.G.</given-names></name><name><surname>Anido</surname><given-names>A.E.</given-names></name><name><surname>Paquin</surname><given-names>J.J.</given-names></name><name><surname>Yadav-Shah</surname><given-names>M.</given-names></name><name><surname>Sherman</surname><given-names>S.L.</given-names></name></person-group>
<article-title>Association of FMR1 repeat size with ovarian dysfunction</article-title>
<source/>Hum. Reprod.
<year>2005</year>
<volume>20</volume>
<fpage>402</fpage>
<lpage>412</lpage>
<pub-id pub-id-type="doi">10.1093/humrep/deh635</pub-id>
<pub-id pub-id-type="pmid">15608041</pub-id></element-citation>
</ref>
<ref id="B117-genes-07-00123">
<label>117.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wittenberger</surname><given-names>M.D.</given-names></name><name><surname>Hagerman</surname><given-names>R.J.</given-names></name><name><surname>Sherman</surname><given-names>S.L.</given-names></name><name><surname>McConkie-Rosell</surname><given-names>A.</given-names></name><name><surname>Welt</surname><given-names>C.K.</given-names></name><name><surname>Rebar</surname><given-names>R.W.</given-names></name><name><surname>Corrigan</surname><given-names>E.C.</given-names></name><name><surname>Simpson</surname><given-names>J.L.</given-names></name><name><surname>Nelson</surname><given-names>L.M.</given-names></name></person-group>
<article-title>The FMR1 premutation and reproduction</article-title>
<source/>Fertil. Steril.
<year>2007</year>
<volume>87</volume>
<fpage>456</fpage>
<lpage>465</lpage>
<pub-id pub-id-type="doi">10.1016/j.fertnstert.2006.09.004</pub-id>
<pub-id pub-id-type="pmid">17074338</pub-id></element-citation>
</ref>
<ref id="B118-genes-07-00123">
<label>118.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Streuli</surname><given-names>I.</given-names></name><name><surname>Fraisse</surname><given-names>T.</given-names></name><name><surname>Ibecheole</surname><given-names>V.</given-names></name><name><surname>Moix</surname><given-names>I.</given-names></name><name><surname>Morris</surname><given-names>M.A.</given-names></name><name><surname>de Ziegler</surname><given-names>D.</given-names></name></person-group>
<article-title>Intermediate and premutation FMR1 alleles in women with occult primary ovarian insufficiency</article-title>
<source/>Fertil. Steril.
<year>2009</year>
<volume>92</volume>
<fpage>464</fpage>
<lpage>470</lpage>
<pub-id pub-id-type="doi">10.1016/j.fertnstert.2008.07.007</pub-id>
<pub-id pub-id-type="pmid">18973899</pub-id></element-citation>
</ref>
<ref id="B119-genes-07-00123">
<label>119.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Allen</surname><given-names>E.G.</given-names></name><name><surname>Sullivan</surname><given-names>A.K.</given-names></name><name><surname>Marcus</surname><given-names>M.</given-names></name><name><surname>Small</surname><given-names>C.</given-names></name><name><surname>Dominguez</surname><given-names>C.</given-names></name><name><surname>Epstein</surname><given-names>M.P.</given-names></name><name><surname>Charen</surname><given-names>K.</given-names></name><name><surname>He</surname><given-names>W.</given-names></name><name><surname>Taylor</surname><given-names>K.C.</given-names></name><name><surname>Sherman</surname><given-names>S.L.</given-names></name></person-group>
<article-title>Examination of reproductive aging milestones among women who carry the FMR1 premutation</article-title>
<source/>Hum. Reprod.
<year>2007</year>
<volume>22</volume>
<fpage>2142</fpage>
<lpage>2152</lpage>
<pub-id pub-id-type="doi">10.1093/humrep/dem148</pub-id>
<pub-id pub-id-type="pmid">17588953</pub-id></element-citation>
</ref>
<ref id="B120-genes-07-00123">
<label>120.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ennis</surname><given-names>S.</given-names></name><name><surname>Ward</surname><given-names>D.</given-names></name><name><surname>Murray</surname><given-names>A.</given-names></name></person-group>
<article-title>A Non-linear association between CGG repeat number and age of menopause in FMR1 premutation carriers</article-title>
<source/>Eur. J. Hum. Genet.
<year>2006</year>
<volume>14</volume>
<fpage>253</fpage>
<lpage>255</lpage>
<pub-id pub-id-type="doi">10.1038/sj.ejhg.5201510</pub-id>
<pub-id pub-id-type="pmid">16251893</pub-id></element-citation>
</ref>
<ref id="B121-genes-07-00123">
<label>121.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hundscheid</surname><given-names>R.D.</given-names></name><name><surname>Sistermans</surname><given-names>E.A.</given-names></name><name><surname>Thomas</surname><given-names>C.M.</given-names></name><name><surname>Braat</surname><given-names>D.D.</given-names></name><name><surname>Straatman</surname><given-names>H.</given-names></name><name><surname>Kiemeney</surname><given-names>L.A.</given-names></name><name><surname>Oostra</surname><given-names>B.A.</given-names></name><name><surname>Smits</surname><given-names>A.P.</given-names></name></person-group>
<article-title>Imprinting effect in premature ovarian failure confined to paternally inherited fragile X premutations</article-title>
<source/>Am. J. Hum. Genet.
<year>2000</year>
<volume>66</volume>
<fpage>413</fpage>
<lpage>418</lpage>
<pub-id pub-id-type="doi">10.1086/302774</pub-id>
<pub-id pub-id-type="pmid">10677300</pub-id></element-citation>
</ref>
<ref id="B122-genes-07-00123">
<label>122.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Van Esch</surname><given-names>H.</given-names></name><name><surname>Buekenhout</surname><given-names>L.</given-names></name><name><surname>Race</surname><given-names>V.</given-names></name><name><surname>Matthijs</surname><given-names>G.</given-names></name></person-group>
<article-title>Very early premature ovarianfailure in two sisters compound heterozygous for the FMR1 premutation</article-title>
<source/>Eur. J. Med. Genet.
<year>2009</year>
<volume>52</volume>
<fpage>37</fpage>
<lpage>40</lpage>
<pub-id pub-id-type="doi">10.1016/j.ejmg.2008.11.001</pub-id>
<pub-id pub-id-type="pmid">19041959</pub-id></element-citation>
</ref>
<ref id="B123-genes-07-00123">
<label>123.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hundscheid</surname><given-names>R.D.</given-names></name><name><surname>Braat</surname><given-names>D.D.</given-names></name><name><surname>Kiemeney</surname><given-names>L.A.</given-names></name><name><surname>Smits</surname><given-names>A.P.</given-names></name><name><surname>Thomas</surname><given-names>C.M.</given-names></name></person-group>
<article-title>Increased serum FSH in female fragile X premutation carriers with either regular menstrual cycles or on oral contraceptives</article-title>
<source/>Hum. Reprod.
<year>2001</year>
<volume>16</volume>
<fpage>457</fpage>
<lpage>462</lpage>
<pub-id pub-id-type="doi">10.1093/humrep/16.3.457</pub-id>
<pub-id pub-id-type="pmid">11228211</pub-id></element-citation>
</ref>
<ref id="B124-genes-07-00123">
<label>124.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Murray</surname><given-names>A.</given-names></name><name><surname>Webb</surname><given-names>J.</given-names></name><name><surname>MacSwiney</surname><given-names>F.</given-names></name><name><surname>Shipley</surname><given-names>E.L.</given-names></name><name><surname>Morton</surname><given-names>N.E.</given-names></name><name><surname>Conway</surname><given-names>G.S.</given-names></name></person-group>
<article-title>Serum concentrations of follicle stimulating hormone may predict premature ovarian failure in FRAXA premutation women</article-title>
<source/>Hum. Reprod.
<year>1999</year>
<volume>14</volume>
<fpage>1217</fpage>
<lpage>1218</lpage>
<pub-id pub-id-type="doi">10.1093/humrep/14.5.1217</pub-id>
<pub-id pub-id-type="pmid">10325264</pub-id></element-citation>
</ref>
<ref id="B125-genes-07-00123">
<label>125.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Welt</surname><given-names>C.K.</given-names></name><name><surname>Smith</surname><given-names>P.C.</given-names></name><name><surname>Taylor</surname><given-names>A.E.</given-names></name></person-group>
<article-title>Evidence of early ovarian aging in fragile X premutation carriers</article-title>
<source/>J. Clin. Endocrinol. Metab.
<year>2004</year>
<volume>89</volume>
<fpage>4569</fpage>
<lpage>4574</lpage>
<pub-id pub-id-type="doi">10.1210/jc.2004-0347</pub-id>
<pub-id pub-id-type="pmid">15356064</pub-id></element-citation>
</ref>
<ref id="B126-genes-07-00123">
<label>126.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>De Caro</surname><given-names>J.J.</given-names></name><name><surname>Dominguez</surname><given-names>C.</given-names></name><name><surname>Sherman</surname><given-names>S.L.</given-names></name></person-group>
<article-title>Reproductive health of adolescent girls who carry the FMR1 premutation: Expected phenotype based on current knowledge of fragile x-associated primary ovarian insufficiency</article-title>
<source/>Ann. N. Y. Acad. Sci.
<year>2008</year>
<volume>1135</volume>
<fpage>99</fpage>
<lpage>111</lpage>
<pub-id pub-id-type="doi">10.1196/annals.1429.029</pub-id>
<pub-id pub-id-type="pmid">18574214</pub-id></element-citation>
</ref>
<ref id="B127-genes-07-00123">
<label>127.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bretherick</surname><given-names>K.L.</given-names></name><name><surname>Fluker</surname><given-names>M.R.</given-names></name><name><surname>Robinson</surname><given-names>W.P.</given-names></name></person-group>
<article-title>FMR1 repeat sizes in the gray zone and high end of the normal range are associated with premature ovarian failure</article-title>
<source/>Hum. Genet.
<year>2005</year>
<volume>117</volume>
<fpage>376</fpage>
<lpage>382</lpage>
<pub-id pub-id-type="doi">10.1007/s00439-005-1326-8</pub-id>
<pub-id pub-id-type="pmid">16078053</pub-id></element-citation>
</ref>
<ref id="B128-genes-07-00123">
<label>128.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bodega</surname><given-names>B.</given-names></name><name><surname>Bione</surname><given-names>S.</given-names></name><name><surname>Dalprà</surname><given-names>L.</given-names></name><name><surname>Toniolo</surname><given-names>D.</given-names></name><name><surname>Ornaghi</surname><given-names>F.</given-names></name><name><surname>Vegetti</surname><given-names>W.</given-names></name><name><surname>Ginelli</surname><given-names>E.</given-names></name><name><surname>Marozzi</surname><given-names>A.</given-names></name></person-group>
<article-title>Influence of intermediate and uninterrupted FMR1 CGG expansions in premature ovarian failure manifestation</article-title>
<source/>Hum. Reprod.
<year>2006</year>
<volume>21</volume>
<fpage>952</fpage>
<lpage>957</lpage>
<pub-id pub-id-type="doi">10.1093/humrep/dei432</pub-id>
<pub-id pub-id-type="pmid">16361284</pub-id></element-citation>
</ref>
<ref id="B129-genes-07-00123">
<label>129.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pastore</surname><given-names>L.M.</given-names></name><name><surname>Young</surname><given-names>S.L.</given-names></name><name><surname>Baker</surname><given-names>V.L.</given-names></name><name><surname>Karns</surname><given-names>L.B.</given-names></name><name><surname>Williams</surname><given-names>C.D.</given-names></name><name><surname>Silverman</surname><given-names>L.M.</given-names></name></person-group>
<article-title>Elevated prevalence of 35–44 FMR1 trinucleotide repeats in women with diminished ovarian reserve</article-title>
<source/>Reprod. Sci.
<year>2012</year>
<volume>19</volume>
<fpage>1226</fpage>
<lpage>1231</lpage>
<pub-id pub-id-type="doi">10.1177/1933719112446074</pub-id>
<pub-id pub-id-type="pmid">22581803</pub-id></element-citation>
</ref>
<ref id="B130-genes-07-00123">
<label>130.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Karimov</surname><given-names>C.B.</given-names></name><name><surname>Moragianni</surname><given-names>V.A.</given-names></name><name><surname>Cronister</surname><given-names>A.</given-names></name><name><surname>Srouji</surname><given-names>S.</given-names></name><name><surname>Petrozza</surname><given-names>J.</given-names></name><name><surname>Racowsky</surname><given-names>C.</given-names></name><name><surname>Ginsburg</surname><given-names>E.</given-names></name><name><surname>Thornton</surname><given-names>K.L.</given-names></name><name><surname>Welt</surname><given-names>C.K.</given-names></name></person-group>
<article-title>Increased frequency of occult fragile X-associated primary ovarian insufficiency in infertile women with evidence of impaired ovarian function</article-title>
<source/>Hum. Reprod.
<year>2011</year>
<volume>26</volume>
<fpage>2077</fpage>
<lpage>2083</lpage>
<pub-id pub-id-type="doi">10.1093/humrep/der168</pub-id>
<pub-id pub-id-type="pmid">21646280</pub-id></element-citation>
</ref>
<ref id="B131-genes-07-00123">
<label>131.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bennett</surname><given-names>C.E.</given-names></name><name><surname>Conway</surname><given-names>G.S.</given-names></name><name><surname>Macpherson</surname><given-names>J.N.</given-names></name><name><surname>Jacobs</surname><given-names>P.A.</given-names></name><name><surname>Murray</surname><given-names>A.</given-names></name></person-group>
<article-title>Intermediate sized CGG repeat are not a common cause of idiopathic premature ovarian failure</article-title>
<source/>Hum. Reprod.
<year>2010</year>
<volume>25</volume>
<fpage>1335</fpage>
<lpage>1338</lpage>
<pub-id pub-id-type="doi">10.1093/humrep/deq058</pub-id>
<pub-id pub-id-type="pmid">20228389</pub-id></element-citation>
</ref>
<ref id="B132-genes-07-00123">
<label>132.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Murray</surname><given-names>A.</given-names></name><name><surname>Schoemaker</surname><given-names>M.J.</given-names></name><name><surname>Bennett</surname><given-names>C.E.</given-names></name><name><surname>Ennis</surname><given-names>S.</given-names></name><name><surname>Macpherson</surname><given-names>J.N.</given-names></name><name><surname>Jones</surname><given-names>M.</given-names></name><name><surname>Morris</surname><given-names>D.H.</given-names></name><name><surname>Orr</surname><given-names>N.</given-names></name><name><surname>Ashworth</surname><given-names>A.</given-names></name><name><surname>Jacobs</surname><given-names>P.A.</given-names></name><etal></etal></person-group>
<article-title>Population-based estimates of the prevalence of FMR1 expansion mutations in women with early menopause and primary ovarian insufficiency</article-title>
<source/>Genet. Med.
<year>2014</year>
<volume>16</volume>
<fpage>19</fpage>
<lpage>24</lpage>
<pub-id pub-id-type="doi">10.1038/gim.2013.64</pub-id>
<pub-id pub-id-type="pmid">23703681</pub-id></element-citation>
</ref>
<ref id="B133-genes-07-00123">
<label>133.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Voorhuis</surname><given-names>M.</given-names></name><name><surname>Onland-Moret</surname><given-names>N.C.</given-names></name><name><surname>Janse</surname><given-names>F.</given-names></name><name><surname>Ploos van Amstel</surname><given-names>H.K.</given-names></name><name><surname>Goverde</surname><given-names>A.J.</given-names></name><name><surname>Lambalk</surname><given-names>C.B.</given-names></name><name><surname>Laven</surname><given-names>J.S.</given-names></name><name><surname>van der Schouw</surname><given-names>Y.T.</given-names></name><name><surname>Broekmans</surname><given-names>F.J.</given-names></name><name><surname>Fauser</surname><given-names>B.C.</given-names></name></person-group>
<article-title>Dutch Primary Ovarian Insufficiency Consortium. The significance of fragile X mental retardation gene 1 CGG repeat sizes in the normal and intermediate range in women with primary ovarian insufficiency</article-title>
<source/>Hum. Reprod.
<year>2014</year>
<volume>29</volume>
<fpage>1585</fpage>
<lpage>1593</lpage>
<pub-id pub-id-type="doi">10.1093/humrep/deu095</pub-id>
<pub-id pub-id-type="pmid">24812319</pub-id></element-citation>
</ref>
<ref id="B134-genes-07-00123">
<label>134.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tejada</surname><given-names>M.I.</given-names></name><name><surname>García-Alegría</surname><given-names>E.</given-names></name><name><surname>Bilbao</surname><given-names>A.</given-names></name><name><surname>Martínez-Bouzas</surname><given-names>C.</given-names></name><name><surname>Beristain</surname><given-names>E.</given-names></name><name><surname>Poch</surname><given-names>M.</given-names></name><name><surname>Ramos-Arroyo</surname><given-names>M.A.</given-names></name><name><surname>López</surname><given-names>B.</given-names></name><name><surname>Fernández-Carvajal</surname><given-names>I.</given-names></name><name><surname>Ribate</surname><given-names>M.P.</given-names></name><etal></etal></person-group>
<article-title>Analysis of the molecular parameters that could predict the risk of manifesting premature ovarian failure in female premutation carriers of fragile X syndrome</article-title>
<source/>Menopause
<year>2008</year>
<volume>15</volume>
<fpage>945</fpage>
<lpage>949</lpage>
<pub-id pub-id-type="doi">10.1097/gme.0b013e3181647762</pub-id>
<pub-id pub-id-type="pmid">18427356</pub-id></element-citation>
</ref>
<ref id="B135-genes-07-00123">
<label>135.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Schuettler</surname><given-names>J.</given-names></name><name><surname>Peng</surname><given-names>Z.</given-names></name><name><surname>Zimmer</surname><given-names>J.</given-names></name><name><surname>Sinn</surname><given-names>P.</given-names></name><name><surname>von Hagens</surname><given-names>C.</given-names></name><name><surname>Strowitzki</surname><given-names>T.</given-names></name><name><surname>Vogt</surname><given-names>P.H.</given-names></name></person-group>
<article-title>Variable expression of the Fragile X Mental Retardation I (FMR1) gene in patients with premature ovarian failure syndrome is not dependent on number of (CGG)n triplets in exon I</article-title>
<source/>Hum. Reprod.
<year>2011</year>
<volume>26</volume>
<fpage>1241</fpage>
<lpage>1251</lpage>
<pub-id pub-id-type="doi">10.1093/humrep/der018</pub-id>
<pub-id pub-id-type="pmid">21335413</pub-id></element-citation>
</ref>
<ref id="B136-genes-07-00123">
<label>136.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lu</surname><given-names>C.</given-names></name><name><surname>Lin</surname><given-names>L.</given-names></name><name><surname>Tan</surname><given-names>H.</given-names></name><name><surname>Wu</surname><given-names>H.</given-names></name><name><surname>Sherman</surname><given-names>S.L.</given-names></name><name><surname>Gao</surname><given-names>F.</given-names></name><name><surname>Jin</surname><given-names>P.</given-names></name><name><surname>Chen</surname><given-names>D.</given-names></name></person-group>
<article-title>Fragile X premutation RNA is sufficient to cause primary ovarian insufficiency in mice</article-title>
<source/>Hum. Mol. Genet.
<year>2012</year>
<volume>21</volume>
<fpage>5039</fpage>
<lpage>5047</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/dds348</pub-id>
<pub-id pub-id-type="pmid">22914733</pub-id></element-citation>
</ref>
<ref id="B137-genes-07-00123">
<label>137.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hoffman</surname><given-names>G.E.</given-names></name><name><surname>Le</surname><given-names>W.W.</given-names></name><name><surname>Entezam</surname><given-names>A.</given-names></name><name><surname>Otsuka</surname><given-names>N.</given-names></name><name><surname>Tong</surname><given-names>Z.B.</given-names></name><name><surname>Nelson</surname><given-names>L.</given-names></name><name><surname>Flaws</surname><given-names>J.A.</given-names></name><name><surname>McDonald</surname><given-names>J.H.</given-names></name><name><surname>Jafar</surname><given-names>S.</given-names></name><name><surname>Usdin</surname><given-names>K.</given-names></name></person-group>
<article-title>Ovarian abnormalities in a mouse model of fragile X primary ovarian insufficiency</article-title>
<source/>J. Histochem. Cytochem.
<year>2012</year>
<volume>60</volume>
<fpage>439</fpage>
<lpage>456</lpage>
<pub-id pub-id-type="doi">10.1369/0022155412441002</pub-id>
<pub-id pub-id-type="pmid">22470123</pub-id></element-citation>
</ref>
<ref id="B138-genes-07-00123">
<label>138.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rife</surname><given-names>M.</given-names></name><name><surname>Nadal</surname><given-names>A.</given-names></name><name><surname>Mila</surname><given-names>M.</given-names></name><name><surname>Willemsen</surname><given-names>R.</given-names></name></person-group>
<article-title>Immunohistochemical FMRP studies in a full mutated female fetus</article-title>
<source/>Am. J. Med. Genet.
<year>2004</year>
<volume>124A</volume>
<fpage>129</fpage>
<lpage>132</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.a.20342</pub-id>
<pub-id pub-id-type="pmid">14699609</pub-id></element-citation>
</ref>
<ref id="B139-genes-07-00123">
<label>139.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Elizur</surname><given-names>S.E.</given-names></name><name><surname>Lebovitz</surname><given-names>O.</given-names></name><name><surname>Derech-Haim</surname><given-names>S.</given-names></name><name><surname>Dratviman-Storobinsky</surname><given-names>O.</given-names></name><name><surname>Feldman</surname><given-names>B.</given-names></name><name><surname>Dor</surname><given-names>J.</given-names></name><name><surname>Orvieto</surname><given-names>R.</given-names></name><name><surname>Cohen</surname><given-names>Y.</given-names></name></person-group>
<article-title>Elevated levels of FMR1 mRNA in granulosa cells are associated with low ovarian reserve in FMR1 premutation carriers</article-title>
<source/>PLoS ONE
<year>2014</year>
<volume>9</volume>
<elocation-id>e105121</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0105121</pub-id>
<pub-id pub-id-type="pmid">25153074</pub-id></element-citation>
</ref>
<ref id="B140-genes-07-00123">
<label>140.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gleicher</surname><given-names>N.</given-names></name><name><surname>Weghofer</surname><given-names>A.</given-names></name><name><surname>Oktay</surname><given-names>K.</given-names></name><name><surname>Barad</surname><given-names>D.H.</given-names></name></person-group>
<article-title>Relevance of triple CGG repeats in the FMR1 gene to ovarian reserve</article-title>
<source/>Reprod. Biomed. Online
<year>2009</year>
<volume>19</volume>
<fpage>385</fpage>
<lpage>390</lpage>
<pub-id pub-id-type="doi">10.1016/S1472-6483(10)60173-3</pub-id>
<pub-id pub-id-type="pmid">19778484</pub-id></element-citation>
</ref>
<ref id="B141-genes-07-00123">
<label>141.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gleicher</surname><given-names>N.</given-names></name><name><surname>Weghofer</surname><given-names>A.</given-names></name><name><surname>Barad</surname><given-names>D.H.</given-names></name></person-group>
<article-title>Ovarian reserve determinations suggest new function of FMR1 (fragile X gene) in regulating ovarian ageing</article-title>
<source/>Reprod. Biomed. Online
<year>2010</year>
<volume>20</volume>
<fpage>768</fpage>
<lpage>775</lpage>
<pub-id pub-id-type="doi">10.1016/j.rbmo.2010.02.020</pub-id>
<pub-id pub-id-type="pmid">20378415</pub-id></element-citation>
</ref>
</ref-list>
</back>
<floats-group>
<table-wrap id="genes-07-00123-t001" position="float">
<object-id pub-id-type="pii">genes-07-00123-t001_Table 1</object-id>
<label>Table 1</label>
<caption>
<p>Genes that have been associated with primary ovarian insufficiency (POI). Adopted and modified from Qin et al. [<xref ref-type="bibr" rid="B15-genes-07-00123">15</xref>].</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Gene</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Localization</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle"><italic>BMP15</italic>—<italic>Bone morphogenetic protein 15</italic></td>
<td align="center" colspan="1" rowspan="1" valign="middle">Xp11.22</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle"><italic>AR</italic>—<italic>Androgen receptor</italic></td>
<td align="center" colspan="1" rowspan="1" valign="middle">Xq12</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle"><italic>FOXO4</italic>—<italic>Forkhead box O4</italic></td>
<td align="center" colspan="1" rowspan="1" valign="middle">Xq13.1</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle"><italic>POF1B</italic>—<italic>Premature ovarian failure, 1B</italic></td>
<td align="center" colspan="1" rowspan="1" valign="middle">Xq21.2</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle"><italic>DACH2</italic>—<italic>Dachshund family transcription factor 2</italic></td>
<td align="center" colspan="1" rowspan="1" valign="middle">Xq21.3</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle"><italic>PGRMC1</italic>—<italic>Progesterone receptor membrane component 1</italic></td>
<td align="center" colspan="1" rowspan="1" valign="middle">Xq22-q24</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle"><italic>FMR1</italic>—<italic>Fragile X mental retardation 1</italic></td>
<td align="center" colspan="1" rowspan="1" valign="middle">Xq27.3</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle"><italic>FMR2</italic>—<italic>Fragile X mental retardation 2</italic></td>
<td align="center" colspan="1" rowspan="1" valign="middle">Xq28</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle"><italic>FIGLA</italic>—<italic>Folliculogenesis specific bHLH transcription factor</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="middle">2p13.3</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle"><italic>LHR</italic>—<italic>Luteinizing hormone receptor</italic></td>
<td align="center" colspan="1" rowspan="1" valign="middle">2p21</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle"><italic>FSHR</italic>—<italic>Follicle-stimulating hormone receptor</italic></td>
<td align="center" colspan="1" rowspan="1" valign="middle">2p21-p16</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle"><italic>INHA</italic>—<italic>Inhibin A</italic></td>
<td align="center" colspan="1" rowspan="1" valign="middle">2q35</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle"><italic>GDF9</italic>—<italic>Growth differentiation factor 9</italic></td>
<td align="center" colspan="1" rowspan="1" valign="middle">5q31.1</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle"><italic>FOXO3a</italic>—<italic>Forkhead box O3</italic></td>
<td align="center" colspan="1" rowspan="1" valign="middle">6q21</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle"><italic>NOBOX</italic>—<italic>Newborn ovary homeobox gene</italic></td>
<td align="center" colspan="1" rowspan="1" valign="middle">7q35</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle"><italic>STAG3</italic>—<italic>Stromal Antigen 3</italic></td>
<td align="center" colspan="1" rowspan="1" valign="middle">7q22.1</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle"><italic>AMHR2</italic>—<italic>Anti-Mullerian hormone receptor, type II</italic></td>
<td align="center" colspan="1" rowspan="1" valign="middle">12q13</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle"><italic>FOXO1</italic>—<italic>Forkhead box O1</italic></td>
<td align="center" colspan="1" rowspan="1" valign="middle">13q14.1</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle"><italic>SPO11</italic>—<italic>Meiotic protein covalently bound to DSB</italic></td>
<td align="center" colspan="1" rowspan="1" valign="middle">20q13.31</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>DMC1</italic>—<italic>DNA meiotic recombinase 1</italic></td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">22q13.1</td>
</tr>
</tbody>
</table>
</table-wrap>
</floats-group>
</article>
</pmc-articleset>